Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             657 results found
no title author magazine year volume issue page(s) type
1 Ad-1 Failure of protection by long persisting human anti-HEV(IgG) against HEV infection in rhesus monkeys Chauhan, Ashok
1995
3 S p. S130-
1 p.
article
2 Author index 1995
3 S p. S170-S196
27 p.
article
3 F5-8 Adoptive transfer of immunity to hepatitis B Shouval, D
1995
3 S p. S17-
1 p.
article
4 F10-5 Alveolar echinococcosis of the liver: Pathogenesis and treatment Sato, N
1995
3 S p. S29-
1 p.
article
5 F1-5 Analysis of cytokine cascade for P.acnes/LPS induced liver apoptosis Matsui, K
1995
3 S p. S5-
1 p.
article
6 F9-10 A new combination therapy for unresectable hepatocellular carcinoma Beppu, T
1995
3 S p. S27-
1 p.
article
7 F6-1 An overview of diagnostic imaging of hepatocellular carcinoma (Introduction) Ichida, T
1995
3 S p. S18-
1 p.
article
8 F4-3 A study of portal and gastric mucosal hemodynamics in cirrhotic patients with portal-hypertensive gastropathy Hashizume, H
1995
3 S p. S14-
1 p.
article
9 F7-5 Bile acid transport in hepatocytes Takikawa, H
1995
3 S p. S20-
1 p.
article
10 F7-6 Bile canalicular contraction and bile formation Watanabe, S
1995
3 S p. S21-
1 p.
article
11 F9-9 Cancer chemotherapy of hepatocellular carcinoma Falkson, G
1995
3 S p. S27-
1 p.
article
12 F10-6 Clinical aspects of patients with schistosomiasis Japonica and its care Matsumoto, Y
1995
3 S p. S29-
1 p.
article
13 F11-4 Clinical significance of quantitative analysis of virus markers and mutants in therapeutic decisions Brunetto, M.R
1995
3 S p. S31-
1 p.
article
14 F11-8 Clinical usefulness of low dose oral interferon for the treatment of chronic hepatitis B Yasuda, Kiyomi
1995
3 S p. S32-
1 p.
article
15 F8-5 Cloning and characterization of newly described cDNAs from a fat-storing cell library: Possible markers for transformation of fat-storing cells into myofibroblasts Ogata, I
1995
3 S p. S23-
1 p.
article
16 F11-3 Combination therapy of ribavirin plus interferon aifa for chronic hepatitis C Lai, M.Y
1995
3 S p. S31-
1 p.
article
17 F12-5 Confucianism and organ donation in Korea Kim, Soo Tae
1995
3 S p. S35-
1 p.
article
18 F11-2 Current state of treatment for chronic hepatitis C in Japan Iino, S
1995
3 S p. S31-
1 p.
article
19 F10-2 Current status of liver abscess in Japan Uchino, J
1995
3 S p. S28-
1 p.
article
20 F5-1 Current status of treatment liver disease in our unit and future perspective Omata, M
1995
3 S p. S16-
1 p.
article
21 F10-4 Current status on the treatment of amebic liver abscess Romero-Cabell, Raúl
1995
3 S p. S28-
1 p.
article
22 F6-2 Differential diagnosis of small liver tumors by CT, MRI and angiography Matsui, O
1995
3 S p. S18-
1 p.
article
23 F6-4 Diffuse liver disease: Diagnosis by MR imaging Mitchell, D.G
1995
3 S p. S18-
1 p.
article
24 F7-9 Effects of bile acids on the microtubule-dependent motor, kinesin, purified from rabbit liver Kuramitsu, T
1995
3 S p. S21-
1 p.
article
25 F4-8 Effects on gastric circulation following the treatments for portal hypertension in cirrhosis Sezai, S
1995
3 S p. S15-
1 p.
article
26 F2-12 Efficacy of blood screening on the incidence of post-transfusion hepatitis in Japan Yoshizawa, H
1995
3 S p. S10-
1 p.
article
27 F3-5 Enhancement of ADP-ribosylation of the stimuratory GTP-binding protein after alcohol intake in rat liver plasma membranes Nomura, F
1995
3 S p. S12-
1 p.
article
28 F2-2 Epidemiology of viral hepatitis and hepatocellular carcinoma in Italy Craxi, Antonio
1995
3 S p. S8-
1 p.
article
29 F7-8 Evidence for the involvement of vesicular transport in canalicular bile formation-time lapse, cinematographic microfluometric and electron cytochemical analysis Yokomori, H
1995
3 S p. S21-
1 p.
article
30 F1-4 Fas system-mediated liver cell death in type C hepatitis Hayashi, N
1995
3 S p. S5-
1 p.
article
31 F6-6 Functional imaging of the liver via receptor-binding radiopharmaceuticals Vera, David R
1995
3 S p. S19-
1 p.
article
32 F4-5 Gastric microcirculatory changes in portal hypertension, pathophysiological rationale for clinical treatment Piqué, Josep M
1995
3 S p. S14-
1 p.
article
33 F1-10 Gene expression of matrix metalloproteinase and its inhibitor in regenerating liver after partial hepatectomy -comparison with repair process in CCL4-injured liver- Takahara, T
1995
3 S p. S7-
1 p.
article
34 F6-8 Hemodynamic imaging of the liver in various liver diseases Moriyasu, F
1995
3 S p. S19-
1 p.
article
35 F7-4 Hepatic mechanisms for canalicular secretion of bile salts and phospholipid Crawford, J.M
1995
3 S p. S20-
1 p.
article
36 F7-7 Hepatic metabolism and transport of bilirubin and other organic anions Adachi, Yukihiko
1995
3 S p. S21-
1 p.
article
37 F9-8 Hepatocellular carcinoma: differences between Japan and Black Africa Kew, Michael C
1995
3 S p. S26-
1 p.
article
38 F9-1 Hepatocellular carcinoma in Japan Okita, K
1995
3 S p. S25-
1 p.
article
39 F1-9 Hepatocyte growth factor-like/macrophage stimulating protein Harrison, P.M
1995
3 S p. S6-
1 p.
article
40 F12-7 Hepatocyte transplantation in multi-locations of congenitally enzyme deficient rats Nakazawa, F
1995
3 S p. S35-
1 p.
article
41 F10-3 Iatrogenic liver abscess: Mechanism and characteristics Kinoshita, H
1995
3 S p. S28-
1 p.
article
42 F6-5 Imaging findings in cirrhosis-correlation with ex-vivo liver specimens Dodd III, Gerald D
1995
3 S p. S19-
1 p.
article
43 F6-7 Imaging for a sialoglycoprotein receptor: Functional evaluation Kudo, M
1995
3 S p. S19-
1 p.
article
44 F4-4 Intestinal hemodynamics in portal hypertension Joh, Takashi
1995
3 S p. S14-
1 p.
article
45 F4-2 Intrahepatic haemodynamics in portal hypertension Grossman, V.L
1995
3 S p. S14-
1 p.
article
46 F12-9 Intravascular coagulation in the hepatic sinusoids induced by gut-derived substances may cause liver injury following orthotopic liver transplantation (OLTX) in rats Arai, M
1995
3 S p. S36-
1 p.
article
47 F4-6 Large gastric varices protect development of portal-hypertensive gastropathy: A study of 510 cirrhotic patients Iwao, T
1995
3 S p. S15-
1 p.
article
48 F5-7 Liver transplantation in the United States Rakela, Jorge
1995
3 S p. S17-
1 p.
article
49 F12-3 Living related liver transplantation: A review of 150 recipients Tanaka, K
1995
3 S p. S34-
1 p.
article
50 F12-4 Living related partial liver transplantation (LRLT) in adult patients Kawasaki, S
1995
3 S p. S34-
1 p.
article
51 F9-11 Long term effect of proton irradiation for hepatocellular carcinoma Yoshiga, S
1995
3 S p. S27-
1 p.
article
52 F8-7 Mechanism of ito cell activation in rat liver cirhosis induced by a choline-deficient (CD) diet and prevention of ito cell activation by prolyl 4-hydroxylase inhibitor Sakaida, I
1995
3 S p. S23-
1 p.
article
53 F4-7 Membrane studies in cirrhotic cardiomyopathy Lee, S.S
1995
3 S p. S15-
1 p.
article
54 F3-3 Metabolism of acetaldehyde to acetate by rat hepatic P450S; a different metabolic pathway from aldh system Kunitoh, S
1995
3 S p. S11-
1 p.
article
55 F3-8 Microcirculatory disturbance in alcoholic liver disease Takei, Y
1995
3 S p. S12-
1 p.
article
56 F1-3 Molecular and cellular pathogenesis of acute fatal hepatitis in HBV transgenic mouse Ando, K
1995
3 S p. S5-
1 p.
article
57 F2-11 Mother-to-infant transmission of hepatitis B virus and its prevention in Japan Kazuo, Shiraki
1995
3 S p. S10-
1 p.
article
58 F2-8 National stragies for viral hepatitis B & C and HCC in Taiwan Sung, J.L
1995
3 S p. S9-
1 p.
article
59 F11-9 New drugs to chronic hepatitis: Slow-release interferon Matsushima, T
1995
3 S p. S33-
1 p.
article
60 F10-9 Nonsurgical therapy of liver abscess and its limit Yoshida, Hiroshi
1995
3 S p. S30-
1 p.
article
61 F5-6 Non-surgical treatment of hepatocellular carcinoma and future perspectives Shiina, Shuichiro
1995
3 S p. S17-
1 p.
article
62 F5-4 Nucleic acid based therapy of viral hepatitis Wands, J.R
1995
3 S p. S16-
1 p.
article
63 F12-6 Open the door for organ donation in the Far East with Hong Kong University experience Fan, S.T
1995
3 S p. S35-
1 p.
article
64 F10-1 Overview: Etiology and pathophysiology of liver abscess Tsutsumi, V
1995
3 S p. S28-
1 p.
article
65 F12-1 Overview of cadaveric liver transplantation Lynch, Stephen V
1995
3 S p. S34-
1 p.
article
66 F3-1 overview of recent progress in alcoholic liver disease Lumeng, L
1995
3 S p. S11-
1 p.
article
67 F12-2 Overview on living-related liver transplantation Makuuchi, M
1995
3 S p. S34-
1 p.
article
68 F10-7 Pathogenesis and treatment of granulomatous liver abscess Noguchi, T
1995
3 S p. S29-
1 p.
article
69 F9-3 Percutaneous acetic acid injection (PAI) for small hepatocellular carcinoma (HCC) in comparison with percutaneous ethanol injection (PEI) Ohnishi, K
1995
3 S p. S25-
1 p.
article
70 F9-4 Percutaneous microwave coagulation therapy for hepatocellular carcinoma (HCC) Seki, T
1995
3 S p. S25-
1 p.
article
71 F3-4 Polymorphisms in alcohol dehydrogenase 2 gene and alcoholic organ injuries in Japanese alcoholics Yamauchi, M
1995
3 S p. S11-
1 p.
article
72 F1-8 Possible difference in the role of transforming growth factor α and hepatocyte growth factor in liver regeneration Tomiya, T
1995
3 S p. S6-
1 p.
article
73 F11-7 Prediction of response to interferon by typing NS5A region in chronic HCV-1B infection Enomoto, N
1995
3 S p. S32-
1 p.
article
74 F5-5 Predictors of response to interferon and therapeutic options in chronic hepatitis C Alberti, A
1995
3 S p. S17-
1 p.
article
75 F9-7 Present status of treatment of large hepatocellular carcinoma Kurokawa, F
1995
3 S p. S26-
1 p.
article
76 F9-2 Present status of treatment of small hepatocellular carcinoma Tanaka, Masatoshi
1995
3 S p. S25-
1 p.
article
77 F3-10 Progress in the treatment of alcoholic liver disease Lieber, C.S
1995
3 S p. S13-
1 p.
article
78 F7-2 Recent developments in the cellular and molecular basis of bile formation Boyer, James L
1995
3 S p. S20-
1 p.
article
79 F1-6 Recent progress in research for hepatocyte growth factor Tsubouchi, H
1995
3 S p. S6-
1 p.
article
80 F1-2 Recent research progress in Japan Muto, Y
1995
3 S p. S5-
1 p.
article
81 F3-2 Recent trend in research of alcoholic liver disease in Japan Ishii, H
1995
3 S p. S11-
1 p.
article
82 F8-6 Retinoic acid induces biphasic release and activation of latent transforming growth factor-β in rat stellate cell cultures Koda, H
1995
3 S p. S23-
1 p.
article
83 F11-6 RNA sequences related to the effect of interferon in chronic hepatitis C: Hypervariable region (HVR) Akahane, Y
1995
3 S p. S32-
1 p.
article
84 F3-9 Role of cytokines and ITO cells in hepatic fibrosis Tsukamoto, H
1995
3 S p. S13-
1 p.
article
85 F3-7 Role of endotoxin in alcoholic liver disease Kato, S
1995
3 S p. S12-
1 p.
article
86 F3-6 Role of nutrition in alcoholic liver disease Frenh, S
1995
3 S p. S12-
1 p.
article
87 F9-5 Segmental necro-sclerotherapy for hepatocellular carcinoma (HCC) Iwasaki, T
1995
3 S p. S26-
1 p.
article
88 F2-10 Sero-epidemiological study of HBV and HCV infection in P. R. China Guo-Liang, Xia
1995
3 S p. S10-
1 p.
article
89 F2-9 Seroepidemiology of HBV and HCV and the decreasing prevalence rate of HBsAG after launching HB vaccination program in Korea Lee, H.-S
1995
3 S p. S9-
1 p.
article
90 F2-5 Seroepidemiology of HBV and HCV in Bangladesh Khan, Mobin
1995
3 S p. S9-
1 p.
article
91 F2-3 Seroepidemiology of HBV and HCV in India and strategy for its control Tandon, B.N
1995
3 S p. S8-
1 p.
article
92 F2-4 Seroepidemiology of HBV/HCV in Pakistan Zuberi, Sarwar J
1995
3 S p. S8-
1 p.
article
93 F2-6 Seroepidemiology of viral hepatitis B and C in Indonesia Suwignyo, S
1995
3 S p. S9-
1 p.
article
94 F11-5 Serum hepatitis C virus core protein level as predictor of response to interferon-ALFA therapy Mizokami, M
1995
3 S p. S32-
1 p.
article
95 F8-8 Serum markers in hepatic fibrosis Murawaki, Y
1995
3 S p. S23-
1 p.
article
96 F10-10 Solitary and multiple liver abscesses: Backgrounds of the patients and the efficacy of percutaneous drainage Tazawa, J
1995
3 S p. S30-
1 p.
article
97 F2-1 Strategies for prevention of viral hepatitis in the United States Holland, P
1995
3 S p. S8-
1 p.
article
98 F9-6 Surgical treatment of small presymtomatic hepatocellular carcinoma Tang, Z.Y
1995
3 S p. S26-
1 p.
article
99 F8-4 TGF-β and hepatic fibrosis Zern, M.A
1995
3 S p. S22-
1 p.
article
100 F10-8 The five cases of hepatic eosinophilic abscess Seol, Sang-Yong
1995
3 S p. S29-
1 p.
article
101 F12-8 The interaction between hepatic sinusoidal cells causing graft dysfunction in liver transplantation Sakurai, H
1995
3 S p. S35-
1 p.
article
102 F5-2 Therapy of chronic viral hepatitis Hoofnagle, J
1995
3 S p. S16-
1 p.
article
103 F8-3 The role of Ito cells in hepatic fibrosis and portal hypertension Pinzani, Massimo
1995
3 S p. S22-
1 p.
article
104 F8-9 The significance of serum matrix metaloproteinases and tissue inhibitors of metalloproteinases in patients with chronic liver diseases Okazaki, Y
1995
3 S p. S24-
1 p.
article
105 F8-1 Trageted inhibition of type I procollagen synthesis by antisense DNA oligonucleotides Wu, C.H
1995
3 S p. S22-
1 p.
article
106 F8-2 Transcriptional activation of α2(I) collagen promoter following acute liver injury -analysis using transgenic mouse- Inagaki, Y
1995
3 S p. S22-
1 p.
article
107 F1-7 Transcriptional control of liver regeneration Taub, R
1995
3 S p. S6-
1 p.
article
108 F11-1 Treatment for type-B chronic hepatitis Kumada, H
1995
3 S p. S31-
1 p.
article
109 F11-11 Treatment of chronic hepatitis C Bonino, F
1995
3 S p. S33-
1 p.
article
110 F5-3 Treatment of hepatitis in Asia and future perspectives Liaw, Y.F
1995
3 S p. S16-
1 p.
article
111 F7-3 Ultrastructural features of bile formation Sakisaka, Shotaro
1995
3 S p. S20-
1 p.
article
112 F11-10 Usefulness of imiquimod in chronic hepatitis C Nishiyama, Y
1995
3 S p. S33-
1 p.
article
113 F6-3 Use of color doppler energy in the diagnosis of small liver tumor Saito, A
1995
3 S p. S18-
1 p.
article
114 F12-10 Viability of partial liver graft from living donor in pig -comparative study with whole liver graft from cadaver- Ohkohchi, N
1995
3 S p. S36-
1 p.
article
115 P-415 Abnormal expression of MUC1 mucin core protein and mature MUC1 mucin in biliary epithelial cells in cystic liver disease Sasaki, M
1995
3 S p. S140-
1 p.
article
116 P-487 A clinicopathological study on combined hepatocellular and cholangiocarcinoma Taguchi, J
1995
3 S p. S158-
1 p.
article
117 P-528 A comparison of single with double abscess drainage for the treatment of large bacterial liver abscess Yamamoto, T
1995
3 S p. S169-
1 p.
article
118 P-190 Activation of phosphatidylinositol 3-kinase in hepatocyte growth and hepatocellular transformation Sasaki, Y
1995
3 S p. S84-
1 p.
article
119 P-463 Affinities of polymers having galactose with hepatocytes and hepatoma cell lines Yamamoto, M
1995
3 S p. S152-
1 p.
article
120 P-221 A kinetic analysis of reduced glutathione (GSH) transport in rat basolateral liver plasma membrane vesicles (bLPM) Tsukahara, K
1995
3 S p. S92-
1 p.
article
121 P-365 Alteration in T cell subsets during and after prednisone withdrawal in patients with chronic hepatitis B Suzuki, Y
1995
3 S p. S128-
1 p.
article
122 P-67 Alteration of serum hepatitis C virus RNA level in children with chronic hepatitis C Kaji, S
1995
3 S p. S53-
1 p.
article
123 P-416 Alterations of ornithine decarboxylase gene in human hepatocellular carcinoma Koh, N
1995
3 S p. S141-
1 p.
article
124 P-467 Altered glycosylation of serum transferrin as indices of therapeutic effects on hepatocellular carcinoma Suzuki, Y
1995
3 S p. S153-
1 p.
article
125 P-189 Alterlation of hepatic 06-methyl-guanin DNA methyltransferase levels in chronic hepatitis, cirrhosis and hepatocellular carcinoma Liu, J
1995
3 S p. S84-
1 p.
article
126 P-275 Amino acid substitutions in NS5A region of HCV-1B are related to its sensitivity to interferon Sakuma, I
1995
3 S p. S105-
1 p.
article
127 P-440 Analysis for cell proliferation and morphological change after introduction of P53 gene Terai, S
1995
3 S p. S147-
1 p.
article
128 P-118 Analysis of anti-PDC-E2-producing B cell clones in the peripheral blood of a patient with primary biliary cirrhosis Fukushima, N
1995
3 S p. S66-
1 p.
article
129 P-357 Analysis of B-cell clonality in liver-infiltrating lymphocytes in chronic hepatitis Kashii, Y
1995
3 S p. S126-
1 p.
article
130 P-10 Analysis of changes in hepatitis B virus genomes after acute exacerbation of chronic hepatitis B Asahina, Y
1995
3 S p. S39-
1 p.
article
131 P-489 Analysis of HBV-DNA precore mutation in chronic liver disease developed to hepatocellular carcinoma Vamamoto, K
1995
3 S p. S159-
1 p.
article
132 P-52 Analysis of HLA-DRB1 in patients infected with hepatitis C virus Miyamoto, T
1995
3 S p. S49-
1 p.
article
133 P-483 Analysis of hyperplastic foci in the liver by flow-cytometric measurement and AgNOR staining Ikebe, T
1995
3 S p. S157-
1 p.
article
134 P-453 Analysis of invasive activity of human hepatic cancer cell lines Kamiyama, T
1995
3 S p. S150-
1 p.
article
135 P-196 Analysis of pathophysiology after hepatic resection combined with pancreatectomy-long-lasting catabolism following 50% hepatic resection combined with 70% pancreatectomy in rats Okuda, J
1995
3 S p. S85-
1 p.
article
136 P-367 Analysis of T cell receptor usage of T lymphocytes infiltrating in the liver tissue from a patient with chronic type B hepatitis (analysis of CDR3 by inverse polymerase chain reaction) Maru, Y
1995
3 S p. S128-
1 p.
article
137 P-380 Analysis of TCR V β gene in peripheral T lymphocytes before and after interferon therapy of patients with chronic hepatitis type C Sugyo, S
1995
3 S p. S132-
1 p.
article
138 P-74 Analysis of the core region of HCV genome isolated from patients with chronic hepatitis C during intervals of normal alt concentration Arataki, K
1995
3 S p. S55-
1 p.
article
139 P-417 Androgen supplement for castrated TGFα transgenic male mice restored hepatic tumorigenesis Matsumoto, T
1995
3 S p. S141-
1 p.
article
140 P-291 A new attempt to predict efficacy of interferon (IFN) therapy by use of a scoring system for background factors of patients in whom IFN was ineffective against type C chronic hepatitis Shingami, T
1995
3 S p. S109-
1 p.
article
141 P-412 A new liver support system composed of functional human liver cells and a radial flow bioreactor for clinical use Kawada, M
1995
3 S p. S140-
1 p.
article
142 P-28 A new method for RNA extraction agglutination partition method-for diagnosis of type C chronic hepatitis Hasebe, C
1995
3 S p. S43-
1 p.
article
143 P-522 An experimental study of hepatic resection under in situ hypothermic or normothermic perfusion technique Takeuchi, K
1995
3 S p. S167-
1 p.
article
144 P-152 An experimental sturdy on administration of 5FY portal vein and residual hepatic regeneration after partial hepatectomy Hasegawa, K
1995
3 S p. S74-
1 p.
article
145 P-31 Antibody-free hepatitis C virus measured by immunoabsorbed multicyclic RT-PCR may provide new information on the condition of chronic hepatitis C patients Kurihara, C
1995
3 S p. S44-
1 p.
article
146 P-141 Anticoagulant and antibacterial activity of type II phospholipase A2: Possible host-defensive action against fulminant hepatic failure Inada, M
1995
3 S p. S72-
1 p.
article
147 P-459 Antitumor activity of human IL2-activated natural killer cells (A-NK) against hepatocellular carcinoma (HCC) Yasumura, S
1995
3 S p. S151-
1 p.
article
148 P-320 Antiviral effect of interferon (IFN) in combination with liver extract preparation Ishiwata, Y
1995
3 S p. S116-
1 p.
article
149 P-157 Apoptosis in liver of the autopsy cases with acute hepatic failure Yamada, T
1995
3 S p. S76-
1 p.
article
150 P-155 Apoptosis in rat liver after administration of hepatocyte growth factor Nagoshi, S
1995
3 S p. S75-
1 p.
article
151 P-381 Apparent involvement of cellular immunity in the mechanism of hepatic cell damage and dysfunction associated with HCV hepatitis (CHC) patients Shimoide, Y
1995
3 S p. S132-
1 p.
article
152 P-473 Appearance of hepatocellular carcinoma cells along with a course of invasive therapy Komeda, T
1995
3 S p. S155-
1 p.
article
153 P-469 Application of immuno-PCR assay to detect an ultra-low level plasma protein, PIVKA-II Tsujii, H
1995
3 S p. S154-
1 p.
article
154 P-281 A prediction of efficacy of IFN therapy by disappearance of HCV RNA two weeks after the start of therapy Tanaka, M
1995
3 S p. S107-
1 p.
article
155 P-343 A role of portal hemodynamic state in development of portal hypertensive gastro-(colo)-pathy Mine, S
1995
3 S p. S122-
1 p.
article
156 P-468 Association between urinary free fucose and serum levels of glycoprotein-bound fucose in patients with chronic liver disease Nishikawa, F
1995
3 S p. S154-
1 p.
article
157 P-300 Association of platelet GMP140 and thrombocytopenia by interferon therapy in patients with chronic hepatitis C Takahashi, A
1995
3 S p. S111-
1 p.
article
158 P-173 A study of cytoskeltons of the hepatocytes in primary culture as a model for the introduction of hepatocytes into a cell cycle for liver regeneration Furune, T
1995
3 S p. S80-
1 p.
article
159 P-241 A study of dynamic contrast-enhanced ultrasonography for detection of small space-occupying lesions of the liver -about usefulness of digital subtraction- Shimada, S
1995
3 S p. S97-
1 p.
article
160 P-445 A suicide gene therapy of metastasized liver tumors Matsuyama, T
1995
3 S p. S148-
1 p.
article
161 P-116 Autoantibodies against nuclear envelope in patients with primary biliary cirrhosis Onozuka, Y
1995
3 S p. S65-
1 p.
article
162 P-110 Autoantibody against 70KD heat shock protein (HSP) in patients with autoimmune liver diseases Shingai, R
1995
3 S p. S64-
1 p.
article
163 P-305 Autoantibody and target antigen for ANA before and after interferon therapy for chronic hepatitis C Ishiguro, N
1995
3 S p. S113-
1 p.
article
164 P-113 Autophagy and endocytosis of bile duct epithelial cells in PBC Igarashi, T
1995
3 S p. S65-
1 p.
article
165 P-460 Basic studies on GcMAF, a new immunotherapeutic agent, in treatment of liver cancer Homma, S
1995
3 S p. S152-
1 p.
article
166 P-215 Bezafibrate and its mechanism of choleresis Sezai, S
1995
3 S p. S90-
1 p.
article
167 P-27 Bidirectional promoter complex within the X gene of hepatitis B virus and woodchuck hepatitis virus Shimoda, A
1995
3 S p. S43-
1 p.
article
168 P-226 Biliary excretion of various compounds in ehyinylestradiol (EE)-induced cholestasis Takamori, Y
1995
3 S p. S93-
1 p.
article
169 P-82 Biochemical analysis of serum and hepatic 7S fragment of type IV collagen in cheonic liver disease Hosho, K
1995
3 S p. S57-
1 p.
article
170 P-389 Blood hyaluronic acid levels for assessment of early graft function in clinical liver transplantation Suehiro, Taketoshi
1995
3 S p. S134-
1 p.
article
171 P-306 Can interferon prevent hepatocarcinogenesis in type C hepatitis? Takagi, H
1995
3 S p. S113-
1 p.
article
172 P-406 Cell proliferation and apoptosis of intra-hepatic bile duct of rats during its development and maturation Sanzen, T
1995
3 S p. S138-
1 p.
article
173 P-188 Cell-specific and non-cell-specific enhancer activity in a far upstream region of the human α-fetoprotein gene Nakabayashi, H
1995
3 S p. S83-
1 p.
article
174 P-41 Cell transformation by transfection of hepatitis C virus genome segment encoding NS3 Takegami, T
1995
3 S p. S47-
1 p.
article
175 P-172 Cellular polarity in undifferentiated hepatocyte doublets during liver regeneration Yamada, T
1995
3 S p. S79-
1 p.
article
176 P-493 Cellular protein(s) related to genomic instability in HBV-induced hepatocarcinogenesis Kajino, K
1995
3 S p. S160-
1 p.
article
177 P-100 Cerebral glucose metabolism in patients with subclinical hepatic encephalopathy using positron emission tomography Kato, A
1995
3 S p. S61-
1 p.
article
178 P-329 Change in plasma concentration of binding free catecholamines in the portal circulation following the portal ligation in rat Kawai, B
1995
3 S p. S119-
1 p.
article
179 P-194 Change of intracellular calcium concentration of hepatocytes during experimental endotoxemia in rats Akimoto, H
1995
3 S p. S85-
1 p.
article
180 P-525 Changes in serum levels of interleukin-6 & acute phase proteins following hepatic resection Kimura, T
1995
3 S p. S168-
1 p.
article
181 P-301 Changes in serum lipids in patients with chronic hepatitis C during interferon beta therapy Kioka, K
1995
3 S p. S112-
1 p.
article
182 P-144 Changes in serum TNF-α, soluble TNF receptor and ICAM-1 levels in patients with acute viral hepatitis Abe, K
1995
3 S p. S72-
1 p.
article
183 P-145 Changes in serum type IV collagen-degrading metalloproteinases and tissue inhibitor of metalloproteinases in patients with acute liver failure Endo, R
1995
3 S p. S73-
1 p.
article
184 P-150 Changes of gap-junction in carbon tetrachloride-induced liver injury in rats Nakata, Y
1995
3 S p. S74-
1 p.
article
185 P-279 Changes of hepatitis C virus (HCV) RNA titers and HCV quasispecies population in the early phase of interferon therapy for chronic hepatitis C Matsumoto, H
1995
3 S p. S106-
1 p.
article
186 P-75 Changes of hepatitis C-virus RNA quantity in the natural course of chronic hepatitis C and correlation with disease condition Hasebe, C
1995
3 S p. S55-
1 p.
article
187 P-462 Changes of immunological parameters after hepatectomy for hepatocellular carcinoma and effects of ulinastatin Takeuchi, Y
1995
3 S p. S152-
1 p.
article
188 P-391 Changes of nitric oxide levels and sinusoidal endothelial cell function in the grafted liver after orthotopic liver transplantation in dogs Noguchi, T
1995
3 S p. S134-
1 p.
article
189 P-203 Characterization of energy metabolism in patients with acute hepatic failure by indirect calorimetry Tajika, M
1995
3 S p. S87-
1 p.
article
190 P-39 Characterization of hepatitis C virus core protein Yasui, K
1995
3 S p. S46-
1 p.
article
191 P-373 Chronic active hepatitis B patients of acute exacerbation with or without abrupt onset of severe jaundice Lee, Heon Ju
1995
3 S p. S130-
1 p.
article
192 P-404 Chronological changes of bile ducts and peribiliary vascular plexuses in rats after bile duct ligation Haratake, J
1995
3 S p. S138-
1 p.
article
193 P-109 Circulating intercellular adhesion molecule-1 and proinflammatory cytokines in primary biliary cirrhosis Sekiyama, K
1995
3 S p. S64-
1 p.
article
194 P-372 Classification of HBV pre S2 peptide types by using PCR technique and its clinical significance Nishikawa, M
1995
3 S p. S129-
1 p.
article
195 P-48 Class II HLA geno- and haplotypes and progression of hepatitis C Kojima, M
1995
3 S p. S48-
1 p.
article
196 P-521 Clinical and biological significance of high interconversion activity of liver mitochondrial β-hydroxybutyrate dehydrogenase (β-OHBDH) Yamamoto, M
1995
3 S p. S167-
1 p.
article
197 P-8 Clinical and histological studies in idiopathic neonatal hepatitis of non-familial form Tazawa, Y
1995
3 S p. S38-
1 p.
article
198 P-283 Clinical application of a fluorescence enzyme immunoassay for HCV core protein Tanaka, E
1995
3 S p. S107-
1 p.
article
199 P-244 Clinical application of a neural network to analyze parenchymal echo patterns of liver cirrhosis and usefulness for a predictive factor of hepatocellular carcinoma Fukuda, H
1995
3 S p. S97-
1 p.
article
200 P-335 Clinical characteristics of portal hypertension less than 20 cmH2O in cirrhosis Suzuki, T
1995
3 S p. S120-
1 p.
article
201 P-77 Clinical evaluation of liver sonoelasticity by measuring internal forced low frequency vibration Sanada, M
1995
3 S p. S56-
1 p.
article
202 P-266 Clinical evaluation of long-term intermittent administration of interferon-alfa in patients with HBe antigen-positive or negative chronic hepatitis B Hakozaki, Yukiya
1995
3 S p. S103-
1 p.
article
203 P-79 Clinical evaluation of serum TIMP2 and MMP2 levels in patients with acute hepatitis Ebata, M
1995
3 S p. S56-
1 p.
article
204 P-390 Clinical evaluation of transplanted liver function by measurement of indocynanine green (ICG) concentration in bile Mizoe, A
1995
3 S p. S134-
1 p.
article
205 P-304 Clinical findings of blood and progress of opthalmic lesions during interferon therapy for chronic hepatitis C Iida, T
1995
3 S p. S112-
1 p.
article
206 P-12 Clinical implications and an easy method for detection of the precore/core promoter mutant (T1762 A1764) of hepatitis B virus Ohno, N
1995
3 S p. S39-
1 p.
article
207 P-65 Clinical investigation of children with positivity of anti-HCV and with normal liver function test Tajiri, H
1995
3 S p. S53-
1 p.
article
208 P-5 Clinical significance of antibody to E2/NS1 in patients with acute hepatitis C Kobayashi, M
1995
3 S p. S38-
1 p.
article
209 P-22 Clinical significance of deletion in the pre-s region of HBV DNA Kobayashi, T
1995
3 S p. S42-
1 p.
article
210 P-13 Clinical significance of mutations in the core promoter of hepatitis B virus Sugai, Y
1995
3 S p. S40-
1 p.
article
211 P-285 Clinical significance of platelet associated immunoglobulin G in interferon therapy for chronic hepatitis C Hashimoto, Yoshiaki
1995
3 S p. S108-
1 p.
article
212 P-472 Clinical significance of serum AFP -mRNA in the hepatocellular carcinoma (HCC) patient Kanbara, Y
1995
3 S p. S155-
1 p.
article
213 P-260 Clinical significance of the hyperintense basal ganglia on T1-weighted image in patients with chronic liver diseases — Possibility in the early diagnosis of the latent hepatic encephalopathy Kuwahara, N
1995
3 S p. S101-
1 p.
article
214 P-251 Clinical significance of three-dimensional display of CT, MR and SPECT images by computer graphics in liver diseases Kashiwagi, T
1995
3 S p. S99-
1 p.
article
215 P-364 Clinicopathological and immunogenetical study of tiopronin induced hepatic injury Moriguchi, M
1995
3 S p. S127-
1 p.
article
216 P-448 Clinicopathological significance of MMP-2,9, and MT-MMP mRNA expressions in hepatocellular carcinoma and the effect of MMP-9 inhibitor Harada, T
1995
3 S p. S149-
1 p.
article
217 P-6 Clinicopathological study in infants with hepatitis due to cytomegalovirus infection Nakashima, E
1995
3 S p. S38-
1 p.
article
218 P-387 COld storage-induced alteration of hepatic energy metabolizm in isolated and perfused rat liver: Influence of leukocyte accumulation Higuchi, H
1995
3 S p. S133-
1 p.
article
219 P-315 Combination therapy with beta and alfa-2a interferon (IF) to chronic hepatitis C(CH-C) Gibo, Y
1995
3 S p. S115-
1 p.
article
220 P-286 Comparison of bile acid metabolism between responders and nonresponders to IFN in patients with chronic hepatitis C Tanaka, H
1995
3 S p. S108-
1 p.
article
221 P-495 Comparison of core gene sequences of hepatitis C virus (HCV) between Japanese and Chinese patients with hepatocellular carcinoma (HCC) Horle, T
1995
3 S p. S160-
1 p.
article
222 P-34 Comparison of HCV-RNA concentrations and variations of E2/NS1 regions between before and after aids occurence in a patient with hemophilia A and hepatitis C Kobayashi, M
1995
3 S p. S45-
1 p.
article
223 P-163 Continuous HGF supply prevents CCI4-induced acute liver injury in rats Kaido, T
1995
3 S p. S77-
1 p.
article
224 P-432 Conversion of sarcomatous cholangiocarcinoma cells to hepatocyte lineage Enjoji, M
1995
3 S p. S145-
1 p.
article
225 P-280 Correlation between HCV quasi-species population and the effect of interferon therapy in patients with chronic hepatitis C Tomida, T
1995
3 S p. S106-
1 p.
article
226 P-456 Correlation between tumor growth and angiogenesis in hepatic tumors Ueda, K
1995
3 S p. S151-
1 p.
article
227 P-480 Correlation of sinusoidal capillarization and arterial blood supply with the stages of hepatocarcinogenesis of rat Yamamoto, T
1995
3 S p. S157-
1 p.
article
228 P-385 Could hyaluronic acid serve as a marker of warm ischemic injury in the grafted liver? Kimura, J
1995
3 S p. S133-
1 p.
article
229 P-50 Cryoglobulinemia and chronic hepatitis C virus disease among Japanese patients Kakumu, S
1995
3 S p. S49-
1 p.
article
230 P-40 Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C Ito, T
1995
3 S p. S46-
1 p.
article
231 P-400 Current status of a cadaveric liver transplantation program in Japan Yanaga, K
1995
3 S p. S137-
1 p.
article
232 P-426 Cyclin expression in hepatocellular carcinoma and possible mechanism of its overexpression Masaki, N
1995
3 S p. S143-
1 p.
article
233 P-106 Cytokine expression in the liver of primary biliary cirrhosis Nagano, T
1995
3 S p. S63-
1 p.
article
234 P-198 Cytoprotective effect of hepatocyte growth factor (HGF) for acute liver injury in HGF transgenic mice Okano, J
1995
3 S p. S86-
1 p.
article
235 P-197 Cytoprotective effects of dibutyryl cyclic AMP (DBc-AMP) on hypoxia/reoxygenation injury of HepG2 cell line Ayukawa, Kusuo
1995
3 S p. S86-
1 p.
article
236 P-421 Decreased expression and point mutation of CIP1/WAF1 gene in human hepatocellular carcinomas Furutani, M
1995
3 S p. S142-
1 p.
article
237 P-441 Delivery of transferrin-DNA conjugate to hepatoma via transferrin receptor Fujiwara, H
1995
3 S p. S147-
1 p.
article
238 P-457 Detection and evaluation of serum and intrahepatic ICAM-1 in hepatocellular carcinoma Shioda, A
1995
3 S p. S151-
1 p.
article
239 P-479 Detection of albumin and AFP mRNA in the circulation: An indicator of hepatic injury in patients with acute viral hepatitis Sakaguchi, T
1995
3 S p. S156-
1 p.
article
240 P-3 Detection of hepatitis A virus in serum by PCR method Naito, Y
1995
3 S p. S37-
1 p.
article
241 P-496 Detection of hepatitis B virus genome in hepatocellular carcinoma from both hepatitis B surface antigen- and antibody to hepatitis C virus-negative patients: A study using polymerase chain reaction Kamito, H
1995
3 S p. S161-
1 p.
article
242 P-482 Detection of intrahepatic Fas antigen in hepatocellular carcinoma Moriyama, M
1995
3 S p. S157-
1 p.
article
243 P-475 Detection of intrahepatic ICAM-1 in rats with DEN-induced cancer Moriyama, M
1995
3 S p. S155-
1 p.
article
244 P-288 Determination and evaluation of serum titers of human hepatocyte growth factor in chronic hepatitis C Koreeda, H
1995
3 S p. S108-
1 p.
article
245 P-45 Development and immune response to HCV-core DNA vaccine constructs Tokushige, Katsutoshi
1995
3 S p. S48-
1 p.
article
246 P-149 Development of a bioartificial liver using hepatocytes entrapped in EHS gel Noda, N
1995
3 S p. S74-
1 p.
article
247 P-29 Development of strand specific RT-PCR method and its application for detection of the HCV negative strand RNA Narui, J
1995
3 S p. S44-
1 p.
article
248 P-509 Difference of recurrent style between TAE alone and TAE plus PEI therapy in small HCC Oda, T
1995
3 S p. S164-
1 p.
article
249 P-130 Different CYP2E1 genotypes and alcoholic liver disease Tsutsumi, M
1995
3 S p. S69-
1 p.
article
250 P-59 Different distribution of hepatitis C virus serologically defined genotypes in East Asia Mizoguchi, N
1995
3 S p. S51-
1 p.
article
251 P-178 Different sugar chains of AFP produced in acute hepatitis and chronic liver diseases Taketa, K
1995
3 S p. S81-
1 p.
article
252 P-95 Different transcriptional mechanisms control collagen gene expression in a hepatoma cell line and mesenchymal cells Nemoto, T
1995
3 S p. S60-
1 p.
article
253 P-410 Direct activation of the chloride channel in guinea-pig hepatocytes by protein kinase C Koumi, Shin-ichi
1995
3 S p. S139-
1 p.
article
254 P-405 Distinction between lymph vessels and portal vein branches in portal tracts using immunohistochemistry for α- smooth muscle actin Oikawa, H
1995
3 S p. S138-
1 p.
article
255 P-23 Distinguishing between acute and chronic hepatitis B virus infection Maruyama, T
1995
3 S p. S42-
1 p.
article
256 P-356 Distribution of B7-positive cells in liver tissues of various liver diseases Shimizu, T
1995
3 S p. S125-
1 p.
article
257 P-359 Distribution of dendritic cells in portal lymphoid aggregates in the tissue with chronic hepatitis C using serial sections Marui, A
1995
3 S p. S126-
1 p.
article
258 P-388 Donor des-gamma-carboxy prothrombin level is correlated with early graft function after orthotopic liver transplantation Suehiro, Taketoshi
1995
3 S p. S134-
1 p.
article
259 P-7 Double blind placebo controlled trial of a herbal drug combination (JIGREEN) in patients of acute viral hepatitis Habibullah, C.M
1995
3 S p. S38-
1 p.
article
260 P-17 Dual and triple infection with HCV: A clinicopathological study Chien, R.N
1995
3 S p. S41-
1 p.
article
261 P-245 Early evaluation of the effect of non-surgical treatment for hepatocellular carcinoma(HCC) using color doppler ultrasonography and dynamic MRI Kobota, T
1995
3 S p. S98-
1 p.
article
262 P-236 Effect of administration of autologous bile to obstructive jaundice patients Ito, A
1995
3 S p. S95-
1 p.
article
263 P-397 Effect of anti-CD4 monoclonal antibody (OX-38) therapy after liver transplantation in rats Yamaguchi, J
1995
3 S p. S136-
1 p.
article
264 P-382 Effect of bile acids on major histocompatibility complex (MHC) class I gene expression Hirano, F
1995
3 S p. S132-
1 p.
article
265 P-238 Effect of bile acids on phagocytic activity on kupffer cell Funaoka, M
1995
3 S p. S96-
1 p.
article
266 P-411 Effect of catalase and α-tocopherol on cultured hepatocytes Nishikawa, M
1995
3 S p. S139-
1 p.
article
267 P-326 Effect of central thyrotropin-releasing hormone (TRH) on the hepatic microcirculation Tamori, K
1995
3 S p. S118-
1 p.
article
268 P-180 Effect of central tyhrotropin-releasing hormone (TRH) on hepatic proliferation Yoneda, M
1995
3 S p. S81-
1 p.
article
269 P-133 Effect of chronic ethanol treatment on signal transduction systems in hepatocytes action of protein kinase A Nomura, T
1995
3 S p. S70-
1 p.
article
270 P-174 Effect of extracellular matrix on Ca2+ oscillations Kitamura, T
1995
3 S p. S80-
1 p.
article
271 P-209 Effect of glyconeogenic amino acids on liver energy and polyamine levels in rats with acute liver failuret Gotoh,
1995
3 S p. S89-
1 p.
article
272 P-184 Effect of HBx gene on response to growth inhibition by TGF-β Tamura, S
1995
3 S p. S82-
1 p.
article
273 P-204 Effect of high sucrose diet on apolipoprotein gene expression in fatty liver with obesity Inui, Y
1995
3 S p. S87-
1 p.
article
274 P-430 Effect of IL-8 on autocrine growth and production of tumor — Associated substances in human liver tumor cell lines Miyamoto, M
1995
3 S p. S144-
1 p.
article
275 P-84 Effect of interferon alfa on serum markers for hepatic fibrosis in patients with chronic hepatitis C Suou, T
1995
3 S p. S57-
1 p.
article
276 P-269 Effect of α-interferon 2b on selected chronic active hepatitis B patients with abruptly elevated aminotranferases levels Lee, Heon Ju
1995
3 S p. S104-
1 p.
article
277 P-85 Effect of interferon on hepatic fibrosis in chronic hepatitis C: Analysis of hepatic extracellular matrix components using a semiquantitative scoring system (SSS) Kishida, Y
1995
3 S p. S58-
1 p.
article
278 P-207 Effect of interferon on the synthesis of lipids and apolipoproteins in HEPG2 cells Shimazu, N
1995
3 S p. S88-
1 p.
article
279 P-298 Effect of interferon therapy on bone mineral density in chronic hepatitis C patients Shimotani, M
1995
3 S p. S111-
1 p.
article
280 P-379 Effect of interferon therapy on the response of PBMC from chronic hepatitis C patients against HCV core-derived peptides Arichi, T
1995
3 S p. S131-
1 p.
article
281 P-148 Effect of plasmapheresis on removal of circulating endotoxin and cytokine in severe liver diseases Iwai, H
1995
3 S p. S73-
1 p.
article
282 P-78 Effect of synthetic RGD peptide on hepatic fibrosis Mizuhara, Y
1995
3 S p. S56-
1 p.
article
283 P-151 Effect of the EGF-receptor-inhibitor on primary cultured hepatocytes isolated from transgenic mice of transforming growth factor α Ichikawa, T
1995
3 S p. S74-
1 p.
article
284 P-192 Effect of tissue plasminogen activator (t-PA) administration on dimethylnitrosamine(DMN)-induced liver injury in rats Mamata, Y
1995
3 S p. S84-
1 p.
article
285 P-139 Effect of vitamin E deficiency on inhibition of liver regeneration by long-term alcohol administration Tanaka, T
1995
3 S p. S71-
1 p.
article
286 P-450 Effects of angiogenesis inhibitor and anticancer drug to suppress hepatic recurrence after partial hepatectomy for liver metastases in rabbits Mugitani, T
1995
3 S p. S149-
1 p.
article
287 P-498 Effects of chronic habitual alcohol intake on the development and serum HCV RNA levels in C viral hepatocellular carcinoma Kishimoto, Y
1995
3 S p. S161-
1 p.
article
288 P-347 Effects of 9-cis retinoic acid and synthetic retinoids on the production of TNF-α and no by rat Kupffer cells Motomura, K
1995
3 S p. S123-
1 p.
article
289 P-523 Effects of dopamine (DOA) and dobtamine (DOB) on liver function after liver resection Furuta, K
1995
3 S p. S167-
1 p.
article
290 P-500 Effects of hepatitis B virus infection and cigarette smoking on hepatocarcinogenesis among patients with heptitis C virus-related chronic liver diseases; A prospective observation and multivariate analysis of 412 patients Chiba, T
1995
3 S p. S162-
1 p.
article
291 P-302 Effects of interferon on cultured human endothelial cells Ro, S
1995
3 S p. S112-
1 p.
article
292 P-289 Effects of interferon-α on serum human hepatocyte growth factor levels in patients with chronic hepatitis C Tsushima, H
1995
3 S p. S109-
1 p.
article
293 P-339 Effects of misiprostol in patients with liver cirrhosis Chung, Jung Myung
1995
3 S p. S121-
1 p.
article
294 P-362 Effects of SHo-saiko-to for in vitro cytokine production on peripheral blood mono-nuclear cells from patients with chronic viral liver diseases Yamashiki, M
1995
3 S p. S127-
1 p.
article
295 P-235 Effects of tauroursodeoxycholic acid (TUDCA) on ischemia-reperfusion injury of rat livers Ono, T
1995
3 S p. S95-
1 p.
article
296 P-355 Effects of TGF-β 1 and vitamin A on the migration, proliferation and cell death of cultured ITO cells Wang, X.E
1995
3 S p. S125-
1 p.
article
297 P-206 Effects of tryptophan metabolites on liver injury Uesugi, K
1995
3 S p. S88-
1 p.
article
298 P-218 Effects of ursodeoxycholate (UDC) and its conjugates on biliary glutathione excretion Kitaura, K
1995
3 S p. S91-
1 p.
article
299 P-314 Efficacy of long term interferon-β administration for chronic hepatitis C Tanaka, N
1995
3 S p. S115-
1 p.
article
300 P-508 Efficacy of percutaneous acetic acid injection (PAI) alone and PAI following transcatheter hepatic arterial embolization (TAE) for large hepatocellular carcinoma (HCC) Ohnishi, K
1995
3 S p. S164-
1 p.
article
301 P-262 Efficasy of 24 week interferon treatment in patients with chronic hepatitis B Naito, M
1995
3 S p. S102-
1 p.
article
302 P-103 EGF receptors dynamic in experimental liver cirrhosis (LC) Marotta, F
1995
3 S p. S62-
1 p.
article
303 P-91 Electron microscopical observation on stellate cells (SC) in alcoholic liver diseases (ALD) and chronic hepatitis C (CH C) Fujiwara, Mutsunori
1995
3 S p. S59-
1 p.
article
304 P-18 Emergence of precore mutant selected by immune clearance of HBV Chiu, C.T
1995
3 S p. S41-
1 p.
article
305 P-418 Endothelin-1 is an autocrine growth factor for hepatocellular carcinoma Ishibashi, M
1995
3 S p. S141-
1 p.
article
306 P-201 Enhanced liver injury in acatalasemic mice following exposure to carbon tetrachloride Wang, D
1995
3 S p. S87-
1 p.
article
307 P-438 Enhancement of anti-Fas antigen-mediated apoptosis in human hepatocellular carcinoma cell lines in the presence of the protein synthesis inhibitor cycloheximide Yano, H
1995
3 S p. S146-
1 p.
article
308 P-321 Enhancing effect of the mixture of liver extract and flavin adenin dinucleotide on interferon efficacy in patients with chronic hepatitis C Masuda, T
1995
3 S p. S117-
1 p.
article
309 P-220 Enhancing effects of ursodeoxycholic acid (UDCA) on glutathione S-transferase (GST) enzyme activities and isozyme concentrations in mouse liver cytosol Kanai, S
1995
3 S p. S91-
1 p.
article
310 P-63 Entire nucleotide sequence of hepatitis C virus (type 3B OR Tr) isolated from a Japanese patient Chayama, K
1995
3 S p. S52-
1 p.
article
311 P-55 Epidemiological study of hepatitis C virus (HCV) transmission using phylogenetic tree construction Hara, T
1995
3 S p. S50-
1 p.
article
312 P-217 Epimerization of isoursodeoxycholic acid to ursodeoxycholic acid in the rat liver Nakamura, K
1995
3 S p. S91-
1 p.
article
313 P-488 Establishment and characterization of sarcomatous cholangiocarcinoma cell line (ETK-1) Honda, M
1995
3 S p. S159-
1 p.
article
314 P-92 Establishment of a human hepatocyte line from normal human liver tissue using a collagen gel sandwich culture system Kono, Yumi
1995
3 S p. S59-
1 p.
article
315 P-70 Estimation of the number of HCV carriers among healthy people Sasaki, F
1995
3 S p. S54-
1 p.
article
316 P-259 Estimation of the reticulo-endothelial function of the liver and spleen by positron emission computed tomography (PET) Okada, S
1995
3 S p. S101-
1 p.
article
317 P-131 Ethanol oxidation activity by human hepatic cytochrome P450 1A2 Asai, H
1995
3 S p. S69-
1 p.
article
318 P-1 Etiology of fulminant viral hepatitis in urban area of Japan - multicenter study Yoshiba, M
1995
3 S p. S37-
1 p.
article
319 P-512 Evaluation of administration routes on hepatic extraction ratio of adriamycin using hepatic venous isolation and charcoal hemoperfusion Tominaga, M
1995
3 S p. S165-
1 p.
article
320 P-216 Evaluation of energy metabolism related to bile formation in isolated perfused rat liver using 31P-NMR spectroscopy Nakashima, T
1995
3 S p. S90-
1 p.
article
321 P-264 Evaluation of long term (24 weeks) interferon therapy for type B chronic hepatitis Karino, Y
1995
3 S p. S102-
1 p.
article
322 P-429 Evaluation of malignant potential and intratumoral heterogeneity in hepatocellular carcinoma by chromosomal numerical analysis Kimura, H
1995
3 S p. S144-
1 p.
article
323 P-246 Evaluation of MR imaging in hepatoma necrosis caused by percutaneous microwave coagulation therapy Isobe, T
1995
3 S p. S98-
1 p.
article
324 P-337 Evaluation of portal blood flow in patients with chronic liver diseases using ultrasonic doppler methods Hatono, N
1995
3 S p. S121-
1 p.
article
325 P-83 Evaluation of response to IFN therapy using new assay systems for serum type 4 collagen in patients with chronic hepatitis C Saitoh, S
1995
3 S p. S57-
1 p.
article
326 P-68 Evaluation of spontaneous remission in children with chronic hepatitis C Komatsu, H
1995
3 S p. S53-
1 p.
article
327 P-520 Evaluation of the function of residual liver after extended hepatic resection by positron emission tomography using 11C-methionine as tracer of amino acid metabolism Otsuki, K
1995
3 S p. S167-
1 p.
article
328 P-261 Evaluation of the hepatic functional reserve and regeneration after hepatectomy by technetium 99m galactosyl human serum albumin dynamic spect Tani, T
1995
3 S p. S102-
1 p.
article
329 P-402 Evaluation of three-dimensional reconstruction of sinusoids by confocal laser reflection microscopy Yoneyama, K
1995
3 S p. S137-
1 p.
article
330 P-142 Evidence of active release of asialoglycoprotein receptor from HepG2 cells Hisai, H
1995
3 S p. S72-
1 p.
article
331 P-366 Evidence of apoptosis in peripheral T lymphocytes induced in patients with chronic hepatitis B infection Nakamura, K
1995
3 S p. S128-
1 p.
article
332 P-101 Experimental hepatic osteodystrophy in the rat with carbon tetrachloride-induced cirrhosis Nakano, A
1995
3 S p. S62-
1 p.
article
333 P-193 Experimental study on remnant liver failure after extensive hepatectomy using an isolated kupffer cells and hepatocyte co-culture system, with special reference to TXA2 and PGI2 Tanigawa, K
1995
3 S p. S85-
1 p.
article
334 P-111 Expression of apoptosis-related antigens in primary biliary cirrhosis Seki, S
1995
3 S p. S64-
1 p.
article
335 P-436 Expression of basic fibroblast growth factor and its receptor in human hepatocellular carcinoma cell lines Ogasawara, S
1995
3 S p. S146-
1 p.
article
336 P-358 Expression of CD80 (B7/BB-1) in liver tissues of patients with chronic hepatitis C Mochizuki, K
1995
3 S p. S126-
1 p.
article
337 P-132 Expression of different types of γ-glutamyl transpeptidase mRNA in alcohol-fed rat liver Sakamoto, K
1995
3 S p. S69-
1 p.
article
338 P-165 Expression of hepatocyte growth factor (HGF) and HGF activator in carbon tetrachloride-induced acute hepatic injury Ishinoda, Y
1995
3 S p. S78-
1 p.
article
339 P-425 Expression of HNF-1/vHNF-1 ratio is strongly linked to histological differentiation of hepatocellular carcinoma and hepatoblastoma Ninomiya, T
1995
3 S p. S143-
1 p.
article
340 P-486 Expression of MAGE-1 gene in hepatocellular carcinoma Yamashita, N
1995
3 S p. S158-
1 p.
article
341 P-93 Expression of membrane type-matrix metalloproteinase (MT-MMP) in liver fibrosis Takahara, T
1995
3 S p. S60-
1 p.
article
342 P-86 Expression of platelet-derived growth factor and its receptor in livers of patients with chronic liver disease Ikura, Y
1995
3 S p. S58-
1 p.
article
343 P-295 Expression of TGF-β1 in liver tissues and its prognostic value of IFN treatment in patients with chronic hepatitis C Shimomura, Soji
1995
3 S p. S110-
1 p.
article
344 P-477 Expression of the BCR protein as a signal transduction product in human hepatocellular carcinoma Miyazaki, Y
1995
3 S p. S156-
1 p.
article
345 P-423 Expression of thymosin β 4 gene during differentiation of HUH-7 cells Matsunaga, T
1995
3 S p. S142-
1 p.
article
346 P-481 Expression of transforming growth factor alpha and epidermal growth factor receptor in human hepatocellular carcinoma Kira, S
1995
3 S p. S157-
1 p.
article
347 P-394 Expressions of cytochrome P450 within intrasplenically transplanted fetal hepatocytes Kato, K
1995
3 S p. S135-
1 p.
article
348 P-228 Factors affecting subselection of biliary lecithin secretion: Relation to “uncoupling phenomenon” Miura, H
1995
3 S p. S93-
1 p.
article
349 P-277 Factors predictive of response to interferon therapy in patients with hepatitis C virus infection and analyses of nucleotide and amino acid sequences obtained from treated patients Chayama, K
1995
3 S p. S106-
1 p.
article
350 P-419 Farnesy protein transferase inhibitor manumycin inhibits the RAs farnesylation and cell growth, but not the nuclear lamin farnesylation in human tumor cells Nagase, T
1995
3 S p. S141-
1 p.
article
351 P-154 Fas antigen was strongly expressed on the cell surface of the hepatocytes in fulminant hepatitis patients Ryo, K
1995
3 S p. S75-
1 p.
article
352 P-143 Fibrinolysis and fibrinogenolysis in acute hepatic failure Inaba, H
1995
3 S p. S72-
1 p.
article
353 P-46 Floating density of circulating hepatitis C viral particles in patients with hepatitis C virus infection Hino, K
1995
3 S p. S48-
1 p.
article
354 P-49 Flowcytometric analysis of complement receptor type 1 in chronic hepatitis C patients Kanto, T
1995
3 S p. S49-
1 p.
article
355 P-307 Follow-up of patients with chronic hepatitis C treated with interferon: An analysis of long-term responders with positive HCV Takahashi, M
1995
3 S p. S113-
1 p.
article
356 P-349 Functional differences in hepatic macrophages after activation may depend on their expression of CD-14 molecule Mochida, S
1995
3 S p. S124-
1 p.
article
357 P-443 Gene therapy for hepatocellular carcinoma by use of a suicide gene investigation on in vitro and in vivo bystander effect Kuriyama, S
1995
3 S p. S147-
1 p.
article
358 P-446 Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human α-fetoprotein gene promoter Ido, A
1995
3 S p. S148-
1 p.
article
359 P-424 Genetic alteration of P16 (MTS1) and cycline E in HCC and CCC Kita, R
1995
3 S p. S143-
1 p.
article
360 P-474 Genetic alterations of NM23-H1 gene in hepatocellular carcinoma Fujimoto, Y
1995
3 S p. S155-
1 p.
article
361 P-222 Genetic defect of crigler-najjar syndrome type II in Japanese patient Yamamoto, K
1995
3 S p. S92-
1 p.
article
362 P-44 Genetic drift in hypervariable region of viral genome in chimpanzees infected with hepatitis C virus Nakai, K
1995
3 S p. S47-
1 p.
article
363 P-21 Genetic drift of hepatitis B virus precore/core region in long-term follow-up of asymptomatic HBe-Ag-positive carriers Tsubota, A
1995
3 S p. S42-
1 p.
article
364 P-497 Genetic variations of the precore and proximal core regions of hepatitis B virus in serum from Korean patients with hepatocellular carcinoma Park, Young-Min
1995
3 S p. S161-
1 p.
article
365 P-210 Glucose intolerance in patients with chronic liver diseases — Analysis of insulin secretion and sensitivity Kanda, T
1995
3 S p. S89-
1 p.
article
366 P-466 Glycosylation patterns of alpha-fetoprotein (AFP) in special reference to disease category Aoyagi, Y
1995
3 S p. S153-
1 p.
article
367 P-179 Growth-promoting activity of TIMP-1 for hepatoma cells Katano, Y
1995
3 S p. S81-
1 p.
article
368 P-24 HBVs with mutations in the encapsidation signal observed in HBV carriers are potent in packaging of pregenomic RNA Itoh, K
1995
3 S p. S42-
1 p.
article
369 P-51 HCV infection and expression of apoptosis-related antigen on peripheral blood lymphocytes in chronic hepatitis C Torimoto, Y
1995
3 S p. S49-
1 p.
article
370 P-334 Hemodynamic change on the spleen under chronic hepatic disorder using positron emission tomography (PET) Koyama, H
1995
3 S p. S120-
1 p.
article
371 P-341 Hemodynamics of blood drainage route (BDR) and therapy for solitary gastric varices Kokubu, S
1995
3 S p. S122-
1 p.
article
372 P-336 Hemodynamics of IV contrast medium in the liver on dynamic CT scan Ibukuro, K
1995
3 S p. S120-
1 p.
article
373 P-442 Heparin-binding EGF-like growth factor-psudomonas exotoxin, A new targeted toxin for the therapy of liver cell cancer Ono, M
1995
3 S p. S147-
1 p.
article
374 P-413 Hepatic disease in 39 autopsied cases of acquired immune deficiency syndrome Shibayama, T
1995
3 S p. S140-
1 p.
article
375 P-187 Hepatic gene therapy: Gene delivery and expression in cirrhotic liver Koura, T
1995
3 S p. S83-
1 p.
article
376 P-186 Hepatic gene therapy: Relationship between gene delivery, expression and aging Kaji, K
1995
3 S p. S83-
1 p.
article
377 P-175 Hepatic injury and regeneration after transient ischemia of rat liver Akashi, T
1995
3 S p. S80-
1 p.
article
378 P-267 Hepatitis B virus variants and response to interferon Aikawa, T
1995
3 S p. S103-
1 p.
article
379 P-15 Hepatitis B virus variants: Protective efficacy of licensed vaccines against infection with a surface mutant which emerged in an immunized infant Ogata, Norio
1995
3 S p. S40-
1 p.
article
380 P-64 Hepatitis C virus infection in pediatric transfusion recipients and its natural course Yamashita, Y
1995
3 S p. S52-
1 p.
article
381 P-377 Hepatitis C virus-specific cytotoxic T lymphocyte responses and viral status in chronic hepatitis C virus infection Hiroishi, K
1995
3 S p. S131-
1 p.
article
382 P-162 Hepatocyte growth factor prevents the onset and progress of dimethylnitrosamine-induced liver cirrhosis in rats Matsuda, Y
1995
3 S p. S77-
1 p.
article
383 P-161 Hepatocyte growth-promoting factor (pHGF) induce apoptosis in proliferating human hepatocellualar carcinoma cells in vitro Yulin, Wei
1995
3 S p. S77-
1 p.
article
384 P-167 Hepatocyte proliferation induced in rats by lead nitrate is suppressed by several tumor necrosis factor-α inhibitors Kubo, Y
1995
3 S p. S78-
1 p.
article
385 P-398 Hepatocyte transplantation — Indian experience Habibulla, C.M
1995
3 S p. S136-
1 p.
article
386 P-137 Hepatocytotic clearance of lipopolysaccharide in chronically alcohol-fed rats Mimura, Y
1995
3 S p. S71-
1 p.
article
387 P-433 HGF and c-met expression in LEC rats in various phases of liver diseases Nakayama, N
1995
3 S p. S145-
1 p.
article
388 P-271 High incidence of hepatitis B, C virus and HIV infections among intravenous drug abusers in Guangxi Province, Southern China Ge, X.M
1995
3 S p. S104-
1 p.
article
389 P-54 High prevalence of thyroid auto-antibodies in patients with chronic hepatitis C Huang, M.J
1995
3 S p. S50-
1 p.
article
390 P-408 Histochemical study on repeated liver biopsies of chronic hepatitis C Kage, M
1995
3 S p. S139-
1 p.
article
391 P-292 Histological predictors of response to interferon treatment on chronic hepatitis C Matsunaga, T
1995
3 S p. S109-
1 p.
article
392 P-312 Histological response of interferon therapy in chronic hepatitis C Shimizu, T
1995
3 S p. S114-
1 p.
article
393 P-403 Histopathological assessment of the liver of patients with chronic hepatitis C before and after interferon (IFN) treatment: HAI score and evaluation of lymphoid follicle, fatty change, and iron deposition Iiyama, K
1995
3 S p. S137-
1 p.
article
394 P-123 Histopathological re-evaluation of interlobular bile duct damage in patients with autoimmune hepatitis (AIH) in Japan Takahashi, Y
1995
3 S p. S67-
1 p.
article
395 P-128 Histopathological study of noncancerous liver tissue in alcoholic liver disease complicated by hepatocellular carcinoma Taniai, M
1995
3 S p. S68-
1 p.
article
396 P-396 HSS induced proliferation of intrasplenically transplanted hepatocytes Sawa, M
1995
3 S p. S136-
1 p.
article
397 P-185 Human hepatitis B virus enhancer 1 is responsive to human interleukin-6 Ohno, H
1995
3 S p. S83-
1 p.
article
398 P-135 Hydrogen peroxide mediates ethanol-induced mitochondrial dysfunction in rat hepatocytes Tomita, K
1995
3 S p. S70-
1 p.
article
399 P-122 Identification of immunodominant T cell epitopes of pyruvate dehydrogenase complexes in primary biliary cirrhosis Shimoda, S
1995
3 S p. S67-
1 p.
article
400 P-376 Identification of ‘native’ peptides bound to class I HLA molecules on hepatocyte membrane Sakuma, J
1995
3 S p. S131-
1 p.
article
401 P-378 IFN-α and -γ production in patients with chronic hepatitis C Uno, K
1995
3 S p. S131-
1 p.
article
402 P-369 Immune response to viral antigens produced by transgene of full-length HBV in purebred mice Hasegawa, K
1995
3 S p. S129-
1 p.
article
403 P-454 Immunohistochemical detection of the receptor for urokinase plasminogen activator in hepatocellular carcinoma Akahane, T
1995
3 S p. S150-
1 p.
article
404 P-407 Immunohistochemical expression of HLA-DR antigen in the portal area of the liver in patients with biliary atresia (BA): comparative study with congenital cystic dilatation of common bile duct (CC) Koike, J
1995
3 S p. S138-
1 p.
article
405 P-164 Immunohistochemical studies on the expression of HGF and HGH receptor in carbon tetrachloride-treated monkeys Matsushita, R
1995
3 S p. S77-
1 p.
article
406 P-360 Immunohistochemical study of CD45RO-positive memory T cells in chronic hepatitis C; effect of interferon therapy Yamada, M
1995
3 S p. S126-
1 p.
article
407 P-354 Immunohistochemical study of the liver tissue surrounding metastatic liver cancers Terayama, N
1995
3 S p. S125-
1 p.
article
408 P-94 Immunohistochemistry of type IV collagen alpha chains (α1 TO α6) in the liver using NC1 specific monoclonal antibodies Manabe, K
1995
3 S p. S60-
1 p.
article
409 P-282 Improvement of hepatitis C viremia by interferon therapy evaluated by homogenous quantitative assay Komeda, T
1995
3 S p. S107-
1 p.
article
410 P-331 Increased production of nitric oxide and its role in the portal circulation in cirrhotic rats Mizumato, Masaki
1995
3 S p. S119-
1 p.
article
411 P-227 Increased sinusoidal efflux and decreased excretion of bile acids by the inhibition of binding to the cytosol Y' bile acid binders (BAB) Takikawa, H
1995
3 S p. S93-
1 p.
article
412 P-363 Increment of T cells expressing CD3low, LFA-1high in inflammatory liver induced by propioni-bacterium acnes and lipopolysaccharide in neonatally thymectomized A/J mice Sanada, E
1995
3 S p. S127-
1 p.
article
413 P-124 Increment of Vβ4-positive cells in liver of neonatally thymectomized A/J mice and experimental hepatitis induced by propionibacterium acnes and lipopolysaccharide Sanada, E
1995
3 S p. S67-
1 p.
article
414 P-524 Indication and limitation of repeat hepatectomy for recurrent hepatocellular carcinoma Uchida, M
1995
3 S p. S168-
1 p.
article
415 P-439 Induction of apoptosis by deprivation of transforming growth factor-alpha in newly established human hepatocellular carcinoma Sakai, Y
1995
3 S p. S146-
1 p.
article
416 P-437 Induction of apoptosis by hepatocyte growth factor (HGF) and interferon γ (IFN γ) in HEP G2 cells Yanagawa, K
1995
3 S p. S146-
1 p.
article
417 P-368 Induction of HLA A2-restricted hepatitis B virus nucleocapsid antigen (HBcAg)- specific cytotoxic T cells (CTL) in patients with chronic hepatitis B Okumura, A
1995
3 S p. S128-
1 p.
article
418 P-112 Induction of nonsuppurative cholangitis by cholangiocyte immunization Ueno, Y
1995
3 S p. S64-
1 p.
article
419 P-147 Induction of peripheral-type benzodiazepine receptors in mouse brain following thioacetamide-induced acute liver failure Kadota, Y
1995
3 S p. S73-
1 p.
article
420 P-136 Influence of dietary zinc on hepatocytotoxicity and lipid peroxidation in rats fed a liquid diet with ethanol and carbonyl iron: Comparison beteen low zinc diet and standard zinc diet Irie, M
1995
3 S p. S70-
1 p.
article
421 P-502 Influence of interferon administration on hepatocellular carcinogenesis from viral cirrhosis Ikeda, Kenji
1995
3 S p. S162-
1 p.
article
422 P-510 Influence of pulsed electric fields to the rat liver Yoshida, T
1995
3 S p. S164-
1 p.
article
423 P-88 Influence of smoking habit on stellate cells in the liver of chronic hepatitis C Fujiwara, Mutsunori
1995
3 S p. S58-
1 p.
article
424 P-299 Influence on glucose tolerance for interferon therapy in patients with chronic hepatitis C Kaneko, K
1995
3 S p. S111-
1 p.
article
425 P-129 Influences of chronic ethanol feeding on kupffer cell-induced mitochondrial dysfunction in hepatoma cells Kurose, I
1995
3 S p. S69-
1 p.
article
426 P-171 Inhibition by ethanol of HGF-induced DNA synthesis and Ca2+ mobilization in rat hepatocytes Saso, K
1995
3 S p. S79-
1 p.
article
427 P-435 Inhibition of proliferation and development of hepatocellular carcinoma by hepatocyte growth factor in transgenic mice Shiota, G
1995
3 S p. S145-
1 p.
article
428 P-96 In situ hybridization of MMP-1 cDNA in small hepatocellular carcinoma Wada, N
1995
3 S p. S60-
1 p.
article
429 P-200 Interaction between hepatocyte and kupffer cell: From the viewpoint of biliary excretion of lipopolysaccharide in the liver Hori, Y
1995
3 S p. S86-
1 p.
article
430 P-239 Interaction of the microtubule cytoskeleton with endocytic vesicles and cytoplasmic dynein in cultured rat hepatocytes Oda, H
1995
3 S p. S96-
1 p.
article
431 P-313 Interferon α and β combination therapy for chronic hepatitis C Yatsuhashi, H
1995
3 S p. S115-
1 p.
article
432 P-316 Interferon-α 2A therapy for chronic hepatitis C-effect of its initial daily administration of longer duration according to HCV RNA level and genotypes Inagaki, Y
1995
3 S p. S115-
1 p.
article
433 P-272 Interferon therapy for type-C chronic hepatitis Arase, Y
1995
3 S p. S104-
1 p.
article
434 P-270 Interferon therapy in chronic viral B hepatitis in Bangladesh: A preliminary report Khan, M
1995
3 S p. S104-
1 p.
article
435 P-268 Interferon treatment of chronic hepatitis B and the mutation of pre-core region of hepatitis B virus Hige, S
1995
3 S p. S103-
1 p.
article
436 P-169 Interleukin-6 induces proliferation of rat hepatocytes in vivo Ohira, H
1995
3 S p. S79-
1 p.
article
437 P-383 Intrahepatic lymphocytes following 70% partial hepatectomy in the rats: Extrathymic T cells in the rats Sato, Y
1995
3 S p. S132-
1 p.
article
438 P-506 Intra-tumorous ethanol injection on absolute non-curative HCC operation Katayama, K
1995
3 S p. S163-
1 p.
article
439 P-414 Investigation of hepatitis virus infection in cases of autopsies Takamatsu, J
1995
3 S p. S140-
1 p.
article
440 P-294 Investigation of interferon receptor transcripts in the liver and PBMC as a predicte of interferon response in chronic hepatitis C Fukuda, R
1995
3 S p. S110-
1 p.
article
441 P-158 Involvement of apoptosis in the process of hepatitis and hepatoma of LEC rats by apoptosis-specific antibody Sugiyama, T
1995
3 S p. S76-
1 p.
article
442 P-492 Involvement of hepatitis B virus for the development of hepatocellular carcinoma-detection of integrated hepatitis B viral sequences in tumor tissue Urashima, T
1995
3 S p. S160-
1 p.
article
443 P-420 Involvement of PP60C-SRC, C-terminal SRC kinase(CSK) and annexin II (AXII) in chronic hepatitis, liver cirrhosis and hepatocellular carcinoma Masaki, Tutomu
1995
3 S p. S142-
1 p.
article
444 P-107 Involvement of TGTα and TGF β in primary biliary cirrhosis Suemori, S
1995
3 S p. S63-
1 p.
article
445 P-516 Involvement of the activity of the MDR gene product, GP170, with PH1 regulation in rat hepatoma cells “in vitro” Pérez de Diego, J
1995
3 S p. S166-
1 p.
article
446 P-205 Iron depletion by feeding with iron-deficient diet prevents the development of liver cancer in LEC rats Kobune, M
1995
3 S p. S88-
1 p.
article
447 P-353 Ischemic injury of hepatic sinusoidal endothelial cell in obstructive jaundice Yoshidome, H
1995
3 S p. S125-
1 p.
article
448 P-159 Kupffer cells may play a role in apoptosis of hepatocytes in allograft rejection after rat liver transplantation Tanaka, Y
1995
3 S p. S76-
1 p.
article
449 PL-6 A minimal and optimal epitope of HLA B44-restricted HCV-specific CTL Kita, H
1995
3 S p. S3-
1 p.
article
450 P-97 Laminin with type IV collagen enhances malignant phenotype of hepatoma cells Torimura, Takuji
1995
3 S p. S61-
1 p.
article
451 PL-11 A novel compound of polyprenoic acids reduced recurrence rates of hepatocellular carcinoma: A double-blind controlled clinical trial Muto, Y
1995
3 S p. S4-
1 p.
article
452 P-98 Late onset ornithine transcarbamylase deficiency in males Yoshino, M
1995
3 S p. S61-
1 p.
article
453 PL-1 Clinical significance of quantitation of hepatitis C virus (HCV) core antigen in serum Tanaka, T
1995
3 S p. S2-
1 p.
article
454 PL-2 Electron microscopic study on virus-like particles in plasma samples from blood donors with non-A, non-B hepatitis (V) -Distribution of E1 and E2/NS1 antigens on HCV particles- Kaito, M
1995
3 S p. S2-
1 p.
article
455 PL-4 Expression of hepatitis C virus envelope proteins in transgenic mice Koike, Kazuhiko
1995
3 S p. S2-
1 p.
article
456 PL-8 Gene expression of LYSYL oxidase in CCl4-induced liver injury Furui, K
1995
3 S p. S3-
1 p.
article
457 PL-10 Gene therapy: Application to the treatment of hepatocellular carcinoma Kaneko, S
1995
3 S p. S4-
1 p.
article
458 PL-3 Gene therapy targeting HCV-RNA and development of the technique for in vivo analysis of HCV-RNA cleavage in gene therapy Yamada, Shuhei
1995
3 S p. S2-
1 p.
article
459 PL-12 Hydroxyethyl adducts in rat liver microsomes: Role in alcoholic liver disease pathogenesis French, S
1995
3 S p. S4-
1 p.
article
460 P-348 Light and electron microscopic studies on the nos-positive cells in the human peripheral blood and liver using NADPH-diaphorase histochemistry Moriyasu, H
1995
3 S p. S123-
1 p.
article
461 P-529 Liver abscess: Evaluation of twentyseven cases Khan, M
1995
3 S p. S169-
1 p.
article
462 P-104 Liver volume in patients with or without liver diseases Lin, X.Z
1995
3 S p. S62-
1 p.
article
463 PL-7 Molecular cloning of rat hepatocyte growth factor (HGF)-activator and its expression following hepatic injury Okajima, A
1995
3 S p. S3-
1 p.
article
464 PL-5 Mutations in the precore/core promoter of hepatitis B virus and their clinical significance Okamoto, H
1995
3 S p. S3-
1 p.
article
465 P-38 Localization of HCV RNA in liver tissue by in situ hybridization Morimoto, H
1995
3 S p. S46-
1 p.
article
466 P-447 Localization of 92KD gelatinase (MMP9) gene transcripts in human hepatocellular carcinoma Ashida, K
1995
3 S p. S148-
1 p.
article
467 P-138 Long-term ethanol treatment affects IL-8 production of cultured chang liver cells Ohira, H
1995
3 S p. S71-
1 p.
article
468 P-319 Long-term follow-up of HCV-infected cirrhotic patients treated with beta-interferon Imazeki, F
1995
3 S p. S116-
1 p.
article
469 P-309 Long-term prognosis of chronic liver disease type C after interferon therapy Chikazawa, H
1995
3 S p. S114-
1 p.
article
470 P-345 Long-term prognosis of idiopathic portal hypertension (IPH): Comparison with liver cirrhosis (LC) and extraphepatic portal obstruction (EHO) Ohashi, Kaoru
1995
3 S p. S123-
1 p.
article
471 P-499 Long term study on the hepatic functional reserve of patients with hepatocellular carcinoma - assessment by maximal removal rate of indocyanine green Maeda, Y
1995
3 S p. S161-
1 p.
article
472 P-310 Long term therapeutic effects of interferon (IFN) on viral hepatitis type C Ono, Tsuyoshi
1995
3 S p. S114-
1 p.
article
473 P-308 Long-term (5 years in average) follow-up of chronic hepatitis C patients after treatment with interferon Matsushita, M
1995
3 S p. S113-
1 p.
article
474 P-254 Loss of phasic oscillations in doppler waveform of hepatic veins in patients with viral cirrhosis Kawanaka, H
1995
3 S p. S100-
1 p.
article
475 PL-9 Role of albumin and HDL as endotoxin binding proteins: Effect of alcohol Kitano, H
1995
3 S p. S4-
1 p.
article
476 P-126 Measurement of self-reactive B lymphocytes in peripheral blood of patients with autoimmune liver disease Ishimaru, Hiroaki
1995
3 S p. S68-
1 p.
article
477 P-444 Mechanism analysis of acquirement of ganciclovir resistance in viral thymidine kinase gene-transduced hepatoma cells Sakamoto, T
1995
3 S p. S148-
1 p.
article
478 P-202 Mechanism of dyslipidemia induced by interferon treatment of chronic hepatitis C Wakashima, M
1995
3 S p. S87-
1 p.
article
479 P-303 Mechanism of the changes of platelet counts during interferon therapy in HCV-positive chronic liver disease (CLD) Azuma, K
1995
3 S p. S112-
1 p.
article
480 P-16 Mechanisms of clearance of HBs antigen and following viral persistence in the patients with chronic hepatitis B Kato, J
1995
3 S p. S40-
1 p.
article
481 P-451 Messenger RNA expression of vascular endothelial growth factor (VEGF) in human hepatoma-derived cell line Kawahara, H
1995
3 S p. S149-
1 p.
article
482 P-146 Metabolic fate of endotoxin in acute hepatic failure of rats induced by D-galactosamine: Role of kupffer cell and splenic macrophage Hoppou, K
1995
3 S p. S73-
1 p.
article
483 P-511 Microwave coagulation therapy for hepatocellular carcinoma associated with liver cirrhosis Sato, M
1995
3 S p. S164-
1 p.
article
484 P-352 Migration and tube-formation of cultured rat sinusoidal endothelial cells Shakado, S
1995
3 S p. S124-
1 p.
article
485 P-494 Molecular biological characteristics of model cells of hepatitis B virus(HBV)-induced direct hepatocarcinogenesis — HBV-DNA integration analysis by fish method Baba, M
1995
3 S p. S160-
1 p.
article
486 P-62 Molecular evolutionary classification of hepatitis C virus based on phylogenetic trees and genetic distance Ohba, K
1995
3 S p. S52-
1 p.
article
487 P-449 Molecular mechanisms of intrahepatic metastasis of hepatocellular carcinoma Osada, Takuya
1995
3 S p. S149-
1 p.
article
488 P-351 Motogenic action of hepatocyte growth factor for primary cultured hepatocytes and Kupffer cells - Observation of changes of cell-substractum adhesions, especially, focal contact using confocal laser microscope - Mizuno, K
1995
3 S p. S124-
1 p.
article
489 P-9 Mutations in the core promoter/ enhancer II regions of naturally occurring hepatitis B virus variants and analysis of the effects on transcription activities Nishizono, Akira
1995
3 S p. S39-
1 p.
article
490 P-11 Mutations in the core promoter region of HBV genome are associated with hepatocellular injury in chronic HBV carriers Kurosaki, M
1995
3 S p. S39-
1 p.
article
491 P-90 Myofibroblastic transformation of human fetal ito cells Himeno, Hiromi
1995
3 S p. S59-
1 p.
article
492 P-330 Natriuresis and systemic hemodynamic effects of brain natriuretic reptide(BNP) in rats with cirrhosis Komeichi, H
1995
3 S p. S119-
1 p.
article
493 P-66 Natural course of transfusion-transmitted HCV infection in childhood Kozaiwa, K
1995
3 S p. S53-
1 p.
article
494 P-237 Neutrophil-mediated sinusoidal cell injury after extended hepatectomy in cholestattic rats followed by external drainage Ohtsuka, M
1995
3 S p. S96-
1 p.
article
495 P-119 New anti-M2 antibody assay system for the diagnosis of primary biliary cirrhosis Shibata, M
1995
3 S p. S66-
1 p.
article
496 P-249 New diagnostic approach to metastatic liver cancer — angio-helical CT and CT-fluoloscopic marking Sugioka, A
1995
3 S p. S99-
1 p.
article
497 P-61 New genotyping of hepatitis C virus and their geographical distribution Wu, R.R
1995
3 S p. S52-
1 p.
article
498 P-60 New subtypes of HCV type 2 in Guinea Conakry Ruggieri, Anna
1995
3 S p. S51-
1 p.
article
499 P-19 Novel hepatitis B variants in siblings carrier positive for anti-HBs Kobayashi, M
1995
3 S p. S41-
1 p.
article
500 P-214 Nuclear translocation of the glucocorticoid receptor by ursodeoxycholic acid Miura, T
1995
3 S p. S90-
1 p.
article
501 P-57 Nucleotide diversity of hepatitis C virus E2/NS1 region and its correlation with subsequent interferon-α therapy Cao, K
1995
3 S p. S51-
1 p.
article
502 P-35 Nucleotide sequence diversity in E2/NS1 gene of hepatitis C virus particles in Japanese hemophiliacs with chronic hepatitis C Toyoda, H
1995
3 S p. S45-
1 p.
article
503 P-134 Okadaic acid, a protein phosphatase inhibitor, enhances ethanol-induced desensitization of receptor-mediated phospholipase C activation in isolated rat hepatocytes Higashi, K
1995
3 S p. S70-
1 p.
article
504 P-484 Overexpression of 27-kDa heat shock proteins in cholangiocarcinoma: A immunohistochemical study Wakayama, Tomohiko
1995
3 S p. S158-
1 p.
article
505 P-213 Papaverine(PA) suppresses vasopressin(VP)-induced phospholipase C activation in the rat liver Yamada, H
1995
3 S p. S90-
1 p.
article
506 P-176 Participation of intestine-derived cytokines in liver regeneration following liver resection Higashiguchi, T
1995
3 S p. S80-
1 p.
article
507 P-231 Pathgenesis of calcified gallstone-CaCO3 supersaturation of gallbladder bile and its relationship with mucus hypersecretion Tomida, Shinji
1995
3 S p. S94-
1 p.
article
508 P-108 Pathogenetic significance of the elevation of soluble ICAM-1 in sera of patients with primary biliary cirrhosis (PBC) Kamegaya, Y
1995
3 S p. S63-
1 p.
article
509 P-105 Pathologic changes of the hepatic graft-versus-host disease (GVHD) across minor histocompatibility barriers in relation to eosinophil infiltration Nonomura, A
1995
3 S p. S63-
1 p.
article
510 P-121 PBC-like lesion in induced by immunization with recombinant PDC-E2/BCKD-E2 hybrid molecule and lipopolysaccharide injection in neonatally thymectomized mice Masanaga, T
1995
3 S p. S67-
1 p.
article
511 P-505 Percutaneous ethanol injection; A role in multidisciprinary treatment of hepatocellular carcinoma Ito, K
1995
3 S p. S163-
1 p.
article
512 P-485 P-glycoprotein expression in hepatocellular carcinoma-from the view of histological differentiation and chemotherapy Tada, K
1995
3 S p. S158-
1 p.
article
513 P-258 Physiological hepatic imaging by positron emission tomography (PET) Taniguchi, H
1995
3 S p. S101-
1 p.
article
514 P-80 Plasma TIMP and TGF-β1 in patients with chronic liver disease and hepatocellular carcinoma Nishimura, Y
1995
3 S p. S56-
1 p.
article
515 P-89 Plasmin inhibitors suppress the release and activation of transforming growth factor-β in rat stellate cell cultures Okuno, M
1995
3 S p. S59-
1 p.
article
516 P-490 Polymerase chain reaction analysis of hepatitis B virus DNA sequences in hepatocellular carcinomas from patients negative for hepatitis B surface antigen and positive for anti-HCV antibody Nambu, S
1995
3 S p. S159-
1 p.
article
517 P-33 Porphyria cutanea tarda and HCV infection Kondo, M
1995
3 S p. S45-
1 p.
article
518 P-340 Portal flow hemodynamics in non-cirrhotic portal fibrosis by doppler sonography Chawla, Y
1995
3 S p. S121-
1 p.
article
519 P-333 Portal hemodynamic changes in patients with normal and injured liver before and after hepatectomy Takaya, Y
1995
3 S p. S120-
1 p.
article
520 P-224 Possible causes leading to conjugated hyperbilirubinemia in mutant(EHBR) rats Uesawa, Y
1995
3 S p. S92-
1 p.
article
521 P-461 Possible involvement of transforming growth factor-β1 in the immunosuppression in patients with advanced malignant diseases Ito, N
1995
3 S p. S152-
1 p.
article
522 P-515 Potentiation by amiloride of doxorubicin effect on normal and tumor liver cells “in vitro” Pérez de Diego, J
1995
3 S p. S165-
1 p.
article
523 P-273 Prediction of HCV-RNA titer change after interferon therapy by PCR-SSCP analysis of 5′-noncoding region Ishiyama, N
1995
3 S p. S105-
1 p.
article
524 P-293 Prediction of response to interferon (IFN) by serum markers of liver fibrosis in chronic hepatitis C Miyabayashi, C
1995
3 S p. S110-
1 p.
article
525 P-296 Predictions of interferon responsiveness in patients with chronic hepatitis C by serum hyaluronate and ICAM-1 levels Matsunaga, T
1995
3 S p. S110-
1 p.
article
526 P-476 Presence of inducible nitric oxide syntase immunoreactivity in hepatocytes from various liver diseases Kono, T
1995
3 S p. S156-
1 p.
article
527 P-399 Preservation and transportation of graft for cadaveric liver transplant in Japan Hoshima, M
1995
3 S p. S136-
1 p.
article
528 P-117 Prevalence and significance of anti-centromere antibody (ACA) in PBC Abe, K
1995
3 S p. S66-
1 p.
article
529 P-504 Prevalence of hepatitis C antibody in patients with chronic liver diseases and hepatocellular carcinoma in Korea Han, B.H
1995
3 S p. S163-
1 p.
article
530 P-4 Prevalence of hepatitis E virus markers in patients with acute hepatitis in Japan Fukushima, S
1995
3 S p. S37-
1 p.
article
531 P-257 Prognosis of primary biliary cirrhosis decided from scintigraphy Tc-99m-labelled GSA Ogami, M
1995
3 S p. S101-
1 p.
article
532 P-471 Prospective analysis on the course of patients with hepatocellular carcinoma (HCC) by AFP mRNA in blood Matsumura, M
1995
3 S p. S154-
1 p.
article
533 P-181 Putrescine as a comitogen in cultured rat hepatocytes and its action site(s) Nagoshi, S
1995
3 S p. S82-
1 p.
article
534 P-248 Qualitative assessment of small hepatocellular carcinoma (HCC) by magnetic resonance imaging Kitamoto, M
1995
3 S p. S98-
1 p.
article
535 P-478 Quantification of α-fetoprotein(AFP) and albumin mRNAs in human hepatocellular carcinoma (HCC) Niwa, Y
1995
3 S p. S156-
1 p.
article
536 P-32 Quantitation of serum HCV core protein level in patients with various HCV genotypes Orito, E
1995
3 S p. S44-
1 p.
article
537 P-256 Quantitative evaluation of hepatic reserve with 99mTc-DTPA-galactosyl-human serum albumin Koreeda, Chizu
1995
3 S p. S100-
1 p.
article
538 P-240 Quantitative evaluation of the arterial hemodynamics of well-differentiated hepato-cellular carcinoma by enhanced ultrasono-graphy Miyajima, Y
1995
3 S p. S96-
1 p.
article
539 P-30 Quantitative measurement of HCV RNA by amplicor and its clinical application Ichijo, T
1995
3 S p. S44-
1 p.
article
540 P-37 Quasispecies of hepatitis C virus and genetic drift of the hypervariable region in chronic type C hepatitis Kao, J.H
1995
3 S p. S46-
1 p.
article
541 P-346 Reciprocal blood flow compensation of portal vein obstruction — angiographic features Chang, Jae-chun
1995
3 S p. S123-
1 p.
article
542 P-318 Recombinant α-interferon treatement of chronic hepatitis C — A comparison of four protocols according to HCV genotypes and serum HCV-RNA levels Takahashi, M
1995
3 S p. S116-
1 p.
article
543 P-517 Reduction of hepatic acute phase response after partial hepatectomy in elderly patients Kimura, O.F
1995
3 S p. S166-
1 p.
article
544 P-428 Reduction of telomeres in chronic liver diseases Kitada, T
1995
3 S p. S144-
1 p.
article
545 P-211 Regulation of albumin gene expression in carbon tetrachloride-induced liver cell injury Obara, H
1995
3 S p. S89-
1 p.
article
546 P-232 Regulation of biliary lipid secretion by bile salt hydrophobicity: Relation to degree of hydrophobic-hydrophilic balance of lecithin species Miyake, H
1995
3 S p. S94-
1 p.
article
547 P-208 Regulation of the valine catabolism in human liver: Comparison between normal liver and cirrhotic liver Taniguchi, K
1995
3 S p. S88-
1 p.
article
548 P-328 Relationship between hepatic oxygen metabolism and hepatic venous hemoglobin oxygen saturation after hepatectomy in rats Yoshioka, S
1995
3 S p. S118-
1 p.
article
549 P-76 Relationship between hepatitis C virus and progression of hepatic lesions in hepatitis C diseases Matsumura, H
1995
3 S p. S55-
1 p.
article
550 P-153 Relationship between inhibitory effect of activin A on hepatocyte proliferation and appearance of connexin gap junctional protein Mine, T
1995
3 S p. S75-
1 p.
article
551 P-384 Relationship between quantitation of hepatitis C virus RNA by competitive PCR, and its genotype and regional specific Ab responses Yoon, Seung Kew
1995
3 S p. S133-
1 p.
article
552 P-393 Relationships between nitroxide radical pharmacokinetics and the changes of pO2 in a mouse liver using in vivo ESR spectroscopy Inaba, K
1995
3 S p. S135-
1 p.
article
553 P-253 Renal hemodynamics in cirrhosis evaluated by velocity wave form analysis using duplex doppler ultrasonography Koda, M
1995
3 S p. S100-
1 p.
article
554 P-513 Repeated arterial infusion chemotherapy using implantable drug delivery system in 100 patients with hepatocellular carcinoma Ihaya, T
1995
3 S p. S165-
1 p.
article
555 P-43 Replication of hepatitis C virus in cloned human T cell lymphotropic virus type-I infected cell line (MT-2) Mizutani, Tetsuya
1995
3 S p. S47-
1 p.
article
556 P-422 Repression of glucocorticoid-inducible gene expression by a novel DNA-binding protein in a nuclear extract from the rat hepatoma cell line M1.19 Tanaka, H
1995
3 S p. S142-
1 p.
article
557 P-427 Restriction landmark genomescanning analysis of chromosomal DNA in hepatocellular carcinoma Hanafusa, T
1995
3 S p. S143-
1 p.
article
558 P-263 Results of long term treatment of IFN in chronic active hepatitis B Maehara, T
1995
3 S p. S102-
1 p.
article
559 P-168 Role of heparin-binding EGF-like growth factor (HB-EGF) in rat liver regeneration: Cell specificity of HB-EGF gene expression and induction of HGF and TGF-α gene expression by HB-EGF Kiso, S
1995
3 S p. S78-
1 p.
article
560 P-371 Role of γ-interferon to overcome immune response defects in hepatitis B virus transgenic mice Akbar, S.M.F
1995
3 S p. S129-
1 p.
article
561 P-156 Role of liver resident NK cells in endotoxin-induced liver apoptosis Tsutsui, H
1995
3 S p. S75-
1 p.
article
562 P-177 Role of macrophages in regeneration of the liver Hongo, S
1995
3 S p. S81-
1 p.
article
563 P-191 Role of nitric oxide in endotoxin-induced liver injury Takemura, S
1995
3 S p. S84-
1 p.
article
564 P-324 Role of nitric oxide in hepatic microcirculatory dysfunction during endotoxemia Nishida, J
1995
3 S p. S117-
1 p.
article
565 P-327 Role of nitric oxide on hepatic arterial blood flow in rats with CCL4-induced liver injury Tanaka, N
1995
3 S p. S118-
1 p.
article
566 P-455 Role of serum soluble adhesion molecules in the recurrence and progression of hepatocellular carcinoma after resection Une, Y
1995
3 S p. S150-
1 p.
article
567 P-332 Role of the spleen in the remnant liver dysfunction after extensive hepatectomy: with special reference to expression of adhesion molecules and changes in nitric oxide levels in liver tissue Kitagawa, M
1995
3 S p. S119-
1 p.
article
568 P-370 Role of vaccination on viral replication in hepatitis B virus transgenic mice Akbar, S.M.F
1995
3 S p. S129-
1 p.
article
569 P-102 Secondary fibrinolysis is paramount event in liver cirrhosis Takikawa, Y
1995
3 S p. S62-
1 p.
article
570 P-491 Selection of HBV PreC/C gene mutants in the tumor tissue of patients positive or negative for HBsAg Minami, M
1995
3 S p. S159-
1 p.
article
571 P-25 Sequence variations at encapsidation signal and serum alanin aminotransferase in anti-HBe positive HBV carriers Niitsuma, H
1995
3 S p. S43-
1 p.
article
572 P-20 Sequencing analysis of the terminal protein region of the polymerase gene in chronic HBV infection Ohkawa, K
1995
3 S p. S41-
1 p.
article
573 P-229 Sequential changes of bile contents in patients with obstructive jaundice from different etiologies — bile from drainage catheter Chen, Chiung-Yu
1995
3 S p. S94-
1 p.
article
574 P-233 Serial cytotoxicities of various bile acids to cultured rat hepatocytes Nagai, H
1995
3 S p. S95-
1 p.
article
575 P-58 Seroepidemiologic study of hepatitis B and C virus infection among Koreans in Korea Shin, H.R
1995
3 S p. S51-
1 p.
article
576 P-470 Serum anti-p53 antibody in patients with hepatocellular carcinoma Saeki, R
1995
3 S p. S154-
1 p.
article
577 P-114 Serum apolipoprotein E concentration is elevated in primary biliary cirrhosis Nakamura, A
1995
3 S p. S65-
1 p.
article
578 P-81 Serum fibrotic markers in patients with chronic liver disease: Relationship to liver histology Murawaki, Y
1995
3 S p. S57-
1 p.
article
579 P-276 Serum HCV-RNA level and the mutation in the interferon sensitivity determining region of chronic hepatitis C patients with genotype 1B infection Murakami, T
1995
3 S p. S105-
1 p.
article
580 P-36 Serum hepatitis C virus (HCV) levels in HCV infected hemodialysis patients Manabe, K
1995
3 S p. S45-
1 p.
article
581 P-290 Serum hepatitis C virus(HCV) RNA levels and efficacy of interferon(IFN) therapy for chronic hepatitis C in habitual drinkers Ohnishi, K
1995
3 S p. S109-
1 p.
article
582 P-47 Serum levels of IL-10, s-IL-2R and s-ICAM-1 in HCV carriers Kuzushita, N
1995
3 S p. S48-
1 p.
article
583 P-127 Serum soluble CD4 and soluble CD8 levels in autoimmune liver diseases Hayashida, K
1995
3 S p. S68-
1 p.
article
584 P-375 Serum soluble HLA class I and II molecules in liver disease Terada, S
1995
3 S p. S130-
1 p.
article
585 P-120 Significance of IgM-class anti-PDH in PBC Miyakawa, H
1995
3 S p. S66-
1 p.
article
586 P-361 Significance of the CD5 positive B cells in chronic hepatitis C Tsuno, S
1995
3 S p. S127-
1 p.
article
587 P-230 Simultaneous determination of plasma mevalonate (MVL) and 7α-hydroxy-4-cholesten-3-one (C4) levels for monitoring biliary cholesterol supersaturation in hyperlipoproteinemia (HLP) Shoda, J
1995
3 S p. S94-
1 p.
article
588 P-255 Spatiotemporal measurement of free radical elimination in the abdomen using an in vivo electron spin resonance imaging system Togashi, H
1995
3 S p. S100-
1 p.
article
589 P-401 Staging and grading in chronic hepatitis Inoue, O
1995
3 S p. S137-
1 p.
article
590 P-234 Studies on the calcium metabolism of hormone-induced bile flow and the pharmaco-kinetics of the bile salts in the perfused liver of normal and cholestatic rats Hamada, Y
1995
3 S p. S95-
1 p.
article
591 P-69 Study of perinatal HCV transmission - expression and persistence of HCV RNA in infants' peripheral blood Moriya, T
1995
3 S p. S54-
1 p.
article
592 P-325 Study of relation between oxygen tension in liver tissue and that in portal vein after ischemia/reperfusion Urakami, A
1995
3 S p. S118-
1 p.
article
593 P-297 Study of the cerebral blood flow by 123I-IMP spect during interferon therapy for chronic hepatitis C patients Sasaki, M
1995
3 S p. S111-
1 p.
article
594 P-140 Study on effect of EGF on hepatic tissue PGE2 in rats with acute hepatic failure Komaba, M
1995
3 S p. S71-
1 p.
article
595 P-115 Study on the case of autoimmune cholangiopathy in our facility Kang, J.-H
1995
3 S p. S65-
1 p.
article
596 P-458 Surface expression of B7 on human liver tumor cells and its modulation by cytokines Shimizu, Y
1995
3 S p. S151-
1 p.
article
597 P-71 Survey of incidence of HCV carrier by horizontal transmission Tanaka, J
1995
3 S p. S54-
1 p.
article
598 P-42 Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection Kato, N
1995
3 S p. S47-
1 p.
article
599 P-503 Sustained low serum GPT level below 80 INU in HCV-associated cirrhotic patients by multiagent therapy prevents development of hepatocellular carcinoma Tarao, K
1995
3 S p. S162-
1 p.
article
600 P-212 Tauroursodeoxycholate (TUDC) suppresses a stimulatory effect of dbcAMP on vasopressin (VP)-induced changes in bile flow in isolated perfused rat liver (IPRL) Hayakawa, T
1995
3 S p. S89-
1 p.
article
601 P-125 T-cell receptor V β chain usage of liver infiltrating lymphocyte (LIL) in autoimmune hepatitis (AIH) Kuramoto, A
1995
3 S p. S68-
1 p.
article
602 P-374 T cell response to HBsAg in chronic hepatitis B infection Ahn, S.Y
1995
3 S p. S130-
1 p.
article
603 P-247 The ability to detect and diagnose small HCC with MRI fatsat imaging Kousima, Oyohei
1995
3 S p. S98-
1 p.
article
604 P-452 The accelerating effect of ischemia-reperfusion injury on liver metastasis of rat ascitic hepatoma Maeda, I
1995
3 S p. S150-
1 p.
article
605 P-278 The branched DNA (bDNA) amplification assay as a predictor of response to IFN therapy in children with chronic hepatitis C Fujisawa, T
1995
3 S p. S106-
1 p.
article
606 P-342 The changes of gastric wall blood flows after portal pressure depression in portal hypertension due to liver cirrhosis - Comparison of portal pressure and endoscopic and color Doppler-endoscopic ultrasonic findings between before and after tipss- Nishida, H
1995
3 S p. S122-
1 p.
article
607 P-409 The characters and the functions of hepatic lymphomyeloid cells Arai, Y
1995
3 S p. S139-
1 p.
article
608 P-350 The cross talk between hepatic macrophages and sinusoidal endotherial cells and the microcirculatory disturbances as the mechanism of development of endotoxin induced liver injury Fujita, S
1995
3 S p. S124-
1 p.
article
609 P-465 The dynamics of serum AFP, ALF and IAP during experimental hepatocarcinogenesis in rats with 3′-Me-DAB Nakayama, T
1995
3 S p. S153-
1 p.
article
610 P-225 The effect of ethynyl estradiol treatment (EE) on the lateral diffusion constants of proteins and lipids in plasma membranes of rat hepatocytes Kitani, K
1995
3 S p. S93-
1 p.
article
611 P-434 The effect of hepatocyte growth factor on various human hepatocellular carcinoma cell lines in vitro Iemura, A
1995
3 S p. S145-
1 p.
article
612 P-395 The effect of h-HGF for survival and proliferation of intrasplenically transplanted hepatocytes in rat Nakazawa, F
1995
3 S p. S135-
1 p.
article
613 P-170 The effect of recombinant human hepatocyte growth factor on the functions of rat hepatocytes in primary culture Kamachi, H
1995
3 S p. S79-
1 p.
article
614 P-338 The effects of endoscopic variceal sclerotherapy on systemic and splanchnic hemodynamics: Correlation with Azygos vein blood flow Shijo, H
1995
3 S p. S121-
1 p.
article
615 P-56 The epidemiological studies on HCV genotypes in the endemic area of hepatitis C virus infection where genotype III/2a is highly prevalent Yoda, Y
1995
3 S p. S50-
1 p.
article
616 P-526 The evaluation of liver damage after hepatectomy by serum hyaluronic acid levels Yoshidome, H
1995
3 S p. S168-
1 p.
article
617 P-344 The evaluation of the induction of inducible nitric oxide synthase in gastric mucosa and gastric mucosal blood flow in portal hypertensive gastropathy Irisawa, A
1995
3 S p. S122-
1 p.
article
618 P-386 The F(ab')2 fragment of an anti-ICAM-1 monoclonal antibody attenuates liver injury after orthotopic liver transplantation Takei, Y
1995
3 S p. S133-
1 p.
article
619 P-53 The frequency of TH1 and TH2 in the peripheral blood mononuclear cells from patients with chronic hepatitis C Kobayashi, K
1995
3 S p. S50-
1 p.
article
620 P-99 The mechanism of ammonia-induced increase in chloride ion concentration in rat cultured hippocampal neurons Irie, T
1995
3 S p. S61-
1 p.
article
621 P-199 The mechanism of the primary ischemia/reoxygenation injury from the aspect of iron chelation Ozaki, M
1995
3 S p. S86-
1 p.
article
622 P-223 The mechanisms of biliary excretion of estradiol-17β-glucuronide (E217G) Yamazaki, R
1995
3 S p. S92-
1 p.
article
623 P-317 The method of administration of IFN for chronic hepatitis C Ishii, T
1995
3 S p. S116-
1 p.
article
624 P-311 The pathological findings on interferon therapy for the patients of chronic hepatitis C Sugiyama, T
1995
3 S p. S114-
1 p.
article
625 P-287 The possible role of zinc and metallothionein on the therapeutic effect of INF-α to hepatitis C patients Nagamine, T
1995
3 S p. S108-
1 p.
article
626 P-26 The pre S domain is the major determinant of hepadnaviral host range Ishikawa, T
1995
3 S p. S43-
1 p.
article
627 P-392 The protective effects of prostaglandin E1 on energy status and protein synthesis in acute ischemic liver Nakagohri, T
1995
3 S p. S135-
1 p.
article
628 P-507 Therapeutic modalities for not resectable hepatocellular carcinoma and their estimation Kurokawa, F
1995
3 S p. S163-
1 p.
article
629 P-2 The recent increase of severe type A hepatitis in Chiba area Fujiwara, K
1995
3 S p. S37-
1 p.
article
630 P-501 The recurrence of hepatocellular carcinoma by hepatitis virus Kato, N
1995
3 S p. S162-
1 p.
article
631 P-250 The relationship between distribution of antineoplastic agents injected via the hepatic artery using infusion chamber and postoperative complications Nishino, M
1995
3 S p. S99-
1 p.
article
632 P-274 The relationship between the effect of IFN therapy and the change of hepatitis C virus NS5B Horiike, N
1995
3 S p. S105-
1 p.
article
633 P-166 The role of bFGF in hepatic regeneration after ischemia reperfusion injury in rats Kawachi, S
1995
3 S p. S78-
1 p.
article
634 P-431 The role of interferon regulatory factor-1 on hepatoma cell growth Tada, S
1995
3 S p. S144-
1 p.
article
635 P-195 The role of intracellular calcium on a release of superoxide anion from kupffer cells and the efficacy of PGE1 Kurosawa, H
1995
3 S p. S85-
1 p.
article
636 P-87 The role of protein kinase C in lipocyte activation Ohnuma, E
1995
3 S p. S58-
1 p.
article
637 P-464 The secretion of procathepsin B and changes in its sugar moiety in cultured hepatoma cells Liu, L
1995
3 S p. S153-
1 p.
article
638 P-518 The significance of suppressing the cytokinemia in hepatic resection Shimada, M
1995
3 S p. S166-
1 p.
article
639 P-519 The significance of the change in the value of serum interleukin-8 after hepatic resection Sasaki, Y
1995
3 S p. S166-
1 p.
article
640 P-160 The study of apoptosis with chronic hepatitis C before and after interferon therapy Kim, S
1995
3 S p. S76-
1 p.
article
641 P-14 The study of the correlations between the pathogenesis and the deletion mutant of HBV core lesion Sugata, F
1995
3 S p. S40-
1 p.
article
642 P-73 The virological and histological states of anti-HCV-positive subjects with normal liver biochemical values Shindo, M
1995
3 S p. S55-
1 p.
article
643 P-252 Three dimensional image analysis for the support of liver surgery Maki, Atsuhiko
1995
3 S p. S99-
1 p.
article
644 P-514 Transcatheter arterial embolization therapy for the patient with hepatocellular carcinoma using the left brachial artery approach Watanabe, S
1995
3 S p. S165-
1 p.
article
645 P-183 Transfection of N-acetylglucosaminyl-transferase-III gene suppresses expression of hepatitis B virus gene in a human hepatoma cell line HB611 Miyoshi, E
1995
3 S p. S82-
1 p.
article
646 P-322 Treatment of chronic hepatitis C with interferon beta Jiménez, M
1995
3 S p. S117-
1 p.
article
647 P-323 Twelve months treatment compared to 6 months treatment with α-interferon (IFN-α-2α) in chronic hepatitis C (CIIC). A multi-center randomised trial Manolakopoulos, S
1995
3 S p. S117-
1 p.
article
648 P-265 Twenty-four week administration of IFN-alfa for chronic hepatitis B Kanai, K
1995
3 S p. S103-
1 p.
article
649 P-219 Ursodeoxycholic acid (UDCA) increases biliary secretion of glutathione (GSH) Yoshida, H
1995
3 S p. S91-
1 p.
article
650 P-242 Usefulness of laparoscopic ultrasonography for diagnosis of hepatocellular carcinoma Nakazawa, Y
1995
3 S p. S97-
1 p.
article
651 P-284 Usefulness of PAIgG and serous markers of liver fibrosis in determining the effectiveness of interferon therapy for patients with chronic hepatitis C Iwata, N
1995
3 S p. S107-
1 p.
article
652 P-243 Utility of carbon dioxide-enhanced ultrasonography for detection of viable lesions in treated hepatocellular carcinoma and to assist additional percutaneous ethanol injection therapy Goto, T
1995
3 S p. S97-
1 p.
article
653 P-182 Variation in liver fatty acid binding protein (L-FABP) and peroxisomal β-oxidation (PO) in partially hepatectomized rats is dependent on PPAR de Foronda, M
1995
3 S p. S82-
1 p.
article
654 P-72 Viral genomic features of asymptomatic HCV carriers comparing with chronic hepatitis C Izumi, N
1995
3 S p. S54-
1 p.
article
655 P-527 4 year experience with endoscopic retrograde cholangio - pancreatogram/endoscopic sphincterotomy perforations and its management Chong, R
1995
3 S p. S168-
1 p.
article
656 S-1 New approaches to the treatment of acute liver failure, including the bioartificial liver William, Roger
1995
3 S p. S1-
1 p.
article
657 S-2 Recent advances in targeted gene therapy for liver diseases Wu, George Y
1995
3 S p. S1-
1 p.
article
                             657 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands